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Noncanonical roles of membranous lysyl-tRNA synthetase in transducing 
cell-substrate signaling for invasive dissemination of colon cancer spheroids 












 The cell-adhesion properties of cancer cells can be targeted to block cancer metastasis. 
Although cytosolic lysyl-tRNA synthetase (KRS or KARS) functions in protein synthesis, KRS 
on the plasma membrane is involved in cancer metastasis. It may be hypothesized that KRS is 
involved in adhesion-related intracellular signaling for cancer cell migration and invasion. To 
test this hypothesis, colon cancer cells with modulated KRS protein levels were adhered on 2 
dimension (2D) or embedded in 3D collagen I gel systems and analyzed for cell signaling and 
behaviors, in comparison to heterozygous KRS-/+ mice and clinical colon cancer tissues. 
Although KRS suppression decreased expression of cell-cell adhesion molecules, cells still 
formed colonies without being scattered, supporting an incomplete EMT. Meanwhile, KRS-
suppressed cells still exhibited focal adhesions on laminin, with Tyr397-phopshorylated FAK, 
but they lacked laminin-adhesion-mediated ERK and paxillin activation. Time-lapse imaging 
revealed KRS-dependent cell dissemination (e.g., outbound movement) from the spheroids, 
whereas KRS-suppressed spheroids remained static due to the absence of efficient cell-ECM 
adhesion-mediated outbound crawling movements. KRS, p67LR, and integrin 61 were 
found to interact, presumably to activate ERK for paxillin expression and activation even 
without involvement of FAK, so that specific inhibition of ERK or KRS in parental HCT116 
spheroids blocked dissemination. Furthermore, KRS-suppressed spheroids recovered the 
capacity for dissemination upon the re-introduction of ERK or paxillin. The KRS/ERK/paxillin 
signaling axis was also observed in marginal areas of colon cancer or KRS-/+ mouse tissues. 
Collectively, these observations indicate that KRS can cause cancer cell dissemination via the 






 Cancer metastasis is a complex process involving multiple steps, such as dissemination 
from the primary tumor mass via EMT, migration, and invasion, that occur even before 
intravasation processes [1]. Dissemination from the primary tumor mass can lead to a journey 
of metastatic cancer cells towards distal settlements, and the disseminated cancer cells migrate 
and invade through the stroma to reach vessels or lymph nodes along the way [2]. In addition 
to strategies aimed at the regression of the primary tumor mass through chemoprevention 
and/or radiation, anti-metastatic strategies that block dissemination process, which is an early 
step of metastasis, would be clinically important for achieving a higher cure rate for cancer. 
Numerous signaling or adaptor molecules have been shown to play critical roles in facilitating 
cancer cells to metastasize. Of these molecules, we are interested in revealing the mechanisms 
underlying the roles of aminoacyl-tRNA synthetases in tumorigenesis and metastasis [3]. 
Cytosolic aminoacyl-tRNA synthetases are traditionally and importantly involved in protein 
translation. However, lysyl-tRNA synthetase (KRS) was recently shown to function in immune 
responses [4, 5] as well as in tumor metastasis [6, 7], clearly suggesting additional biological 
functions beyond protein translation. KRS is phosphorylated at the Thr52 residue by 
p38MAPK, which causes it to dissociate from the cytosolic multi-tRNA synthetase (MTS) 
complex and translocate to the plasma membrane, where it associates with and stabilizes a 67 
kDa laminin receptor (p67LR) that is involved in migration and metastasis [6]. p67LR is known 
to associate with integrin 61 [8] or 64 [9], which have roles in cell adhesion to the ECM 
and tumor cell invasion [10]. The association of KRS with p67LR is sufficiently targeted to 
allow the inhibition of KRS-dependent metastasis in a subcutaneously cell-injected animal 
model, suggesting that KRS is a promising target for anti-cancer metastatic strategies [7]. 
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Therefore, as part of our efforts to develop anti-metastatic therapeutics by targeting KRS-
mediated cellular behaviors, we found that KRS might cause cell dissemination from spheroids 
embedded in an ECM-surrounded 3-dimensional (3D) environment. This system would be 
beneficial if the dissemination process observed in 3D gels could be mechanistically related to 
KRS-dependent dissemination in in vivo-like circumstances and could also generally be useful 
as a template screening system for anti-metastasis reagents. This study revealed that KRS 
appears to play regulatory roles in cell adhesion by activating ERK and paxillin during cancer 

















1. Cells  
  HCT116 and SW620 colon cancer (American Type Culture Collection, Manassas, VA, 
USA) and other colon cancer (Korean Cell Bank, Seoul National University) cells were stably 
transfected with shRNA against KRS (transcript 1, NM_001130089, lysyl-tRNA synthetase 
MISSION® shRNA Plasmid DNA, Sigma) using Truefect (United Biosystems, Herndon, VA) 
before antibiotic selections. The target sequences of shKRS and the names of the KRS-
suppressed cell clones are shown in table 1. HCT116 cells overexpressing KRS were 
established via the stable transfection of a myc-tagged KRS plasmid [6]. ERK1 and ERK2 
(ERK clones) and paxillin (PXN clones) were also stably transfected, either separately or 
together (PEE clones for paxillin, ERK1, and ERK2), into KRS-suppressed cell clones. Stable 
myc-tagged KRS and different stable shKRS-transfected clones were established by using 250 
g/ml G418 or 0.50 g/ml puromycin (AG Scientific, Inc., San Diego, CA). The cells were 
maintained in RPMI-1640 (WelGene, Daegu, Korea) containing 10% FBS and antibiotics 
(Invitrogen, Grand Island, NY, USA). 
2. Spheroid formation and embedding into 3D collagen I gels 
  HCT116 or SW620 cells with modulated KRS expression levels, or other colon cancer 
cells were processed for spheroid formation using Perfecta3D® 96-well hanging-drop plates 
(3D Biomatrix, Ann Arbor, MI). Spheroids were selected to be less than 70 m in size  using 
a cell strainer sieve (SPL Life Science Co., Pocheon-si, Korea) prior to being embedded into 
3D collagen I gels (BD Biosciences, San Jose, CA, USA). For embedding, 
polydimethylsiloxane (PDMS) chambers with an 8-mm diameter, or 10 well-slips for 22 x 60 
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mm coverslips (model No.: WL-2260-10, Live Cell Instrument, Seoul, Korea), were filled with 
30 l collagen I (2.0 mg/ml, BD Biosciences) to coat the bottom surfaces of the chamber. 
PDMS (Sylgard 184, Dow Corning, Midland, MI) prepolymer was prepared using a 10:1 (w/w) 
mixture of PDMS base and curing agent, cast against the master and thermally cured to obtain 
a negative replica-molded piece. Spheroids were then mixed with ice-cold collagen I solutions 
(2.0 mg/ml), which were prepared by diluting a concentrated collagen I (BD Biosciences) stock 
with 10 × reconstitution buffer (260 mM sodium bicarbonate and 200 mM HEPES), and 10 × 
RPMI-1640 with phenol red [11]. The pH was adjusted in the range of 7.2 to 7.4 using ice-cold 
2 N NaOH. The mixture was transferred to a 37ºC CO2 incubator to allow the collagen I to 
polymerize and form a fibrillar meshwork. The 3D culture was then refreshed each day with 
standard culture media containing 10 % FBS. 
3. Extract preparation and Western blots 
  Colon cancer cells within collagen I gels were washed with ice-cold PBS and then 
homogenized with truncated pipette tips (3 times × 20 min on ice) in modified RIPA buffer (50 
mM Tris-HCl, 150 mM NaCl, 1% NP-40, and 0.25% sodium deoxycholate) with a protease 
inhibitor cocktail (GenDepot, Barker, TX). The extracts were centrifuged for 30 min at 15,000 
g and 4°C, and then the lysates were collected from the supernatant. The protein amounts were 
normalized with the band intensities for -tubulin or -actin via standard Western blots, 
before further immunoblotting with different antibodies. The primary antibodies used in the 
study were as follows: -tubulin, -SMA, talin, pY822vinculin, and vimentin (Sigma, St Louis, 
MO); pY416c-Src, ERKs, phospho-ERKs, FLAG, pS473Akt, pS425talin, caspase 3, Tensin 2, and 
Akt (Cell Signaling Technol. Danvers, MA); paxillin, N-cadherin, and FAK (BD Biosciences); 
pY397FAK, p67LR, laminin, vinculin, and Twist1 (Abcam, Cambridge, UK); c-Src, 
pY118paxillin, pY577FAK, pY861FAK, pY925FAK, Snail1, E-cadherin, -catenin, and Slug 
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(Santa Cruz Biotech., Santa Cruz, CA); ZO1 (Zymed Laboratories, Camarillo); pY483Tensin 2 
(Biorbyt, San Francisco, CA); vinculin, integrin 6, 1, and 4 (Millipore, Billerica, MA); 
fibronectin (DAKO, Carpinteria, CA); and KRS (Atlas Antibodies, Stockholm, Sweden).  
4. Normal 2D culture or replating on 2D ECM layer 
  Cells were kept in suspension or replated on ECM (10 g/ml, laminin or fibronectin, 
BD Biosciences)-precoated dishes or coverglasses in the absence (in the case of fibronectin) or 
presence of low serum (2%, in the case of laminin) for 1 h before being analyzed for cell-ECM 
adhesion signaling by standard Western blotting or for the formation of focal adhesions by 
indirect immunofluorescence, as described previously [12]. Function blocking antibodies 
against human integrin 6 (Millipore, 20 g/ml) were preincubated with cells by rocking at 
37ºC for 1 h prior to replating. Pharmacological inhibitors were added to the culture media for 
24 h or to replating media at the reseeding time. Cells were reseeded on coverglasses precoated 
with standard media containing 10% FBS, before imaging to monitor cell growth patterns or 
immunofluorescence to detect the formation of cell-cell contacts. Confluent cells were 
wounded with a pipette tip and washed twice with PBS. After treatment with DMSO, U0126 
(10 M, LC Labs., Woburn, MA), or YH16899 (10 M) and incubation in a CO2 incubator for 
24 h, the marginal edges of the wounds were imaged (CKX41, Olympus, Japan). 
5. Time-lapse FRET analysis for ERK activity 
HCT116 cells were cultured on a laminin-coated (5 g/ml) 35-mm glass-base dish and 
were transfected with FRET-based indicators [13] using the lipofectamine 2000 transfection 
reagent (Life Technologies, Grand Island, NY), according to the manufacturer’s instructions. 
FRET images were obtained on a Nikon Ti-E inverted microscope (Nikon, Tokyo, Japan) 
equipped with PFS, a CoolSNAP HQ camera (Roper Scientific, Trenton, NJ), and excitation 
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and emission filter wheels. Images were acquired by using the 44 binning mode and 200-ms 
exposure time. All systems were controlled by MetaMorph software (Molecular Devices, 
Sunnyvale, CA). For dual-emission ratio imaging of the intramolecular FRET probe, we 
obtained images for CFP and FRET. After background subtraction, pseudo-colored images of 
FRET/CFP were created using eight colors from red to blue to represent the FRET/CFP ratio 
via the intensity modulated display (IMD) mode using MetaMorph software. Filters used for 
the dual-emission ratio imaging were purchased from Semrock (Rochester, NY): an FF01-
438/24-25 excitation filter, an FF458-Di02-2536 dichroic mirror, and two emission filters, 
FF01-483/32-25 for CFP and FF01-542/27-25 for FRET.  
6. Time-lapse imaging of cells in 3D ECM gels 
  Parental or stable cells were transfected with mCherry-MT1-MMP for 24 h before 
spheroid formation. Three hours after spheroids were embedded in 3D collagen I gels, time-
lapse images were collected for the indicated periods using IX81-ZDC microscope (Olympus, 
Tokyo, Japan). The microscope was equipped with a 10-well Chamlide Incubator system (Live 
Cell Instrument, Seoul, Korea), and an environmental chamber mounted on the microscope 
maintained constant conditions of 37°C, 5% CO2, and 95% humidity. Pharmacological 
inhibitors such as U0126 (50 M) or YH16899 [50 M, [7]] were mixed during the process of 
embedding the cells into 3D collagen I gels.  
7. Coimmunoprecipitations 
  Whole-cell extracts prepared from cells in standard media containing 10% FBS or 
from cells kept in suspension or reseeded onto laminin (10 g/ml) in media containing 2% FBS 
for 2 h were immunoprecipitated overnight using anti-myc tag antibody-coated agarose beads 
(Sigma). The immunoprecipitated proteins were boiled in 2 × SDS-PAGE sample buffer before 
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standard Western blot analysis. 
8. Indirect immunofluorescence 
  Cells reseeded on 2D normal culture media- or ECM-precoated glass coverslips or 
embedded in 3D collagen I gels within PDMS were immunostained using antibodies against 
E-cadherin, snail1, pERK, K14, or paxillin in addition to DAPI staining for the nucleus. 
Immunofluorescence images were acquired on a fluorescence microscope (BX51TR, 
Olympus, Tokyo, Japan) or a confocal laser scanning microscope with a Nikon Plan-
Apochromat 60×/1.4 N.A. oil objective (Nikon eclipse Ti microscope, Nikon, Tokyo, Japan), 
and then analyzed using the IMARIS imaging software (Bitplane AG, Zurich, Switzerland). 
9. Chromatin immunoprecipitation (ChIP) 
ChIP assays were performed using the ChIP-IT Express kit (Active Motif, Carlsbad, 
CA), following the manufacturer’s protocols. Briefly, cells embedded in collagen I gels for 24 
h were fixed for 30 min with 2% formaldehyde, and the chromatin was then prepared by 
sonication shearing to aid nuclear release and enzymatic shearing. The sheared chromatin was 
immunoprecipitated using c-Jun (Cell Signaling) or Elk-1 (Santa Cruz Biotech.,) antibodies 
and captured with protein G magnetic beads. The chromatin was eluted from the purified 
immunoprecipitates, reversed cross-linked, and digested with proteinase K. The reaction was 
then stopped using proteinase K stop solution. The isolated chromatin was analyzed by 36 
cycles of PCR. Ten microliters of each PCR product was separated via 2% agarose 
electrophoresis and visualized by ethidium bromide staining. 
10. Generation of KRS heterozygote mouse 
  For the generation of KRS heterozygote animals, KRS genetrap ES cells (AJ0130) 
were purchased from the MMRRC and used to generate a chimeric mouse at the UCSD 
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transgenic mouse core facility. The disruption of the gene via the insertion of the genetrap 
cassette into intron 13 was confirmed by genomic PCR using primers flanking the breakpoint 
(forward: 5'- TGG GTT TCA TCC TGA GGT CT - 3'; reverse: 5'- GCT TTC TTT CCC AGG 
TCC TC - 3'; genetrap reverse: 5'-TGT CCT CCA GTC TCC TCC AC - 3'). No viable 
homozygous pups were born, nor were any viable embryos observed (up to embryonic day 9.5). 
We confirmed the reduction of KRS expression levels in the heterozygote in multiple organs 
(Fig. S9). No gross phenotypic differences, including size, weight and movement behavior, 
were observed between wild-type and KRS heterozygote mice (data not shown). MMTV-PyVT 
transgenic mice were purchased from The Jackson Laboratory.  
11. Measurement of metastasis in the MMTV-PyVT transgenic mice 
MMTV-PyVT mice were crossed to KRS heterozygotes to generate the MMTV-PyVT; 
KRS+/+ and MMTV-PyVT; KARS+/GT mice. Female mice were sacrificed at 16 and 18 weeks. 
After the lungs were dissected out and fixed, each lobule was carefully examined under the 
microscope to count the total number of metastatic nodules. A white round bump of over 100 
m on the lung surface was counted as a nodule. 
12. Analyses of murine or human tissues 
  All procedures for animal and human tissues were performed in accordance with the 
procedures of the Seoul National University Laboratory Animal Maintenance Manual and 
Institutional Review Board (IRB) agreement approved by the Institute of Laboratory Animal 
Resources Seoul National University (ILARSNU) and SNUIRB, respectively. Human colon 
tissues were obtained with informed content from patients who received surgery at Samsung 
Medical Center (Sungkyunkwan University School of Medicine, Seoul, Korea) or National 
Biobank of Korea-Pusan National University Hospital (PNUH) in accordance with IRB 
agreements. Whole-tissue extracts were prepared with modified RIPA buffer [12] using a 
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Bullet Blender BBX24 surrounded by dry ice and containing 1.0 mm zirconium silicate beads 
(Next Advance, Inc. Averill Park, NY), prior to standard Western blots for the indicated 
molecules. 
13. Immunohistochemistry 
Dissected breast tumors were fixed and stored in 10% NBF. The tissues were 
processed, paraffin embedded, and sectioned at 6-μm thickness. After deparaffinization, 
antigen retrieval was performed by boiling the sections for 5 min in sodium citrate solution 
(0.01 M, pH 6). The sections were incubated he at 4οC with the indicated antibodies in PBST 
(0.3% Triton X-100 in PBS) containing 5% goat serum or 3% BSA. After washing, the sections 
were incubated with biotin-conjugated anti-rabbit, mouse or goat IgG (1:100, Sigma) antibody 
and ExtrAvidin-peroxidase (1:50, Sigma) at RT for 1 h each for 3,3′-diaminobenzidine 
detection. The sections were counterstained with hematoxylin and imaged under the 
microscope. Immunohistochemistry of serial sections of paired normal or tumor colon tissues 
was performed using normal rabbit IgG, normal mouse IgG, phospho-ERKs (Cell Signaling), 
KRS (Atlas Antibodies), and paxillin (BD Biosciences).  
14. RT-PCR 
  Total RNA was extracted from cells in 2D normal 10% FBS-containing condition or 
ECM-precoated culture dishes with low (2%) serum-containing conditions, or in 3D collagen 
I gels, using TRIzol (Invitrogen) according to the manufacturer’s protocol. One microgram of 
total RNA was reverse transcribed using the amfiRivert Platinum cDNA Synthesis master mix 
(GenDepot). Primers were designed using Primer3 software as follows: human E-cadherin 
(CDH1) mRNA, forward 5’-TGCCCAGAAAATGAAAAAGG-3’ and reverse 5’-
GTGTATGTGGCAATGCGTTC-3’; human N-cadherin (CDH2) mRNA, forward 5’-
ACAGTGGCCACCTACAAAGG-3’ and reverse 5’-CCGAGATGGGGTTGATAATG-3’; 
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human Vimentin (VIM) mRNA, forward 5’-GAGAACTTTGCCGTTGAAGC-3’ and reverse 
5’-GCTTCCTGTAGGTGGCAATC-3’; human Twist (TWIST) mRNA, forward 5’-
GGAGTCCGCAGTCTTACGAG-3’ and reverse 5’-TCTGGAGGACCTGGTAGAGG-3’; 
human paxillin (PXN) mRNA, forward 5’-GAAATCAGCTGAGCCTTCAC-3’ and reverse 5’-
TTAGGCTTCTCTTTCGTCAGG-3’, Snail1, forward 5’-GGTTCTTCTGCGCTACTGCT-3’ 
and reverse 5’-TAGGGCTGCTGGAAGGTAAA-3’; slug, forward 5’-
GGGGAGAAGCCTTTTTCTTG-3’ and reverse 5’-TCCTCATGTTTGTGCAGGAG-3; 
human KRS (KARS) mRNA, forward 5’- CAATGCCCATGCCCCAGCCA-3’ and reverse 5’- 
ACCCCACCCTTCCGGCGAAT-3’, and human -actin (ACTB) mRNA, forward 5’-
TGACGGGGTCACCCACACTGTGCCCATCTA-3’ and reverse 5’-
CTAGAAGCATTTGCGGTGGACGACGGAGGG-3’. 
15. Statistical methods 
Student’s t-test was performed for statistical comparisons of mean values to determine 













Incomplete EMT phenotype upon KRS suppression 
  To explore the roles of KRS in metastatic dissemination, HCT116 colon cancer cells 
with endogenous, suppressed, or overexpressed KRS levels were analyzed for EMT 
phenotypes. Using an RT-PCR approach, we found that KRS suppression decreased E-cadherin 
mRNA (an epithelial marker) but increased the mRNAs of mesenchymal markers (Fig. 1.1A). 
Furthermore, these KRS suppression-dependent changes in EMT markers also carried over to 
protein levels; epithelial markers including E-cadherin were expressed at higher levels in KRS-
expressing parental and KRS-overexpressing HCT116 cells, whereas KRS-suppressed cell 
clones decreased epithelial marker expression and concomitantly enhanced the expression of 
mesenchymal markers (Fig. 1.1B). The increased levels of mesenchymal marker proteins after 
the suppression of KRS to certain levels, without caspase 3 activation, supported additional 
roles for KRS other than protein translation. Meanwhile, KRS-suppressed cell clones did not 
show altered expression of laminin and p67-laminin receptor (p67LR), which are important for 
KRS-mediated tumorigenic roles [3], or integrin chains 6, 1, or 4 compared with KRS-
expressing cells (Fig. 1.1B). E-cadherin and -catenin were not clearly observed in cell-cell 
junctions when KRS was suppressed, as compared with KRS-expressing cells (Fig. 1.1C). 
Therefore, the inverse relationship between KRS and epithelial marker expression may suggest 
the induction of EMT phenotypes. However, cell-cell contacts were not disrupted after KRS 
suppression (Figs. 1.1C and D), suggesting that KRS suppression caused an incomplete EMT.     
KRS-dependent cell-laminin adhesion 
   We then examined the relationship between KRS expression and cell-ECM adhesion 
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properties. First, cells with various KRS expression levels were adhered under normal 10% 
FBS-containing culture conditions and examined for adhesion-related signaling activities. 
Under normal 10% serum-containing 2D culture conditions, KRS suppression abolished the 
signaling activities of FAK, ERK, c-Src, and paxillin (Fig. 1.2A) compared with KRS-
expressing (or overexpressing) cells. Cell adhesion-related signaling activities were then 
analyzed after the cells were kept in suspension or reseeded onto ECM-precoated culture 
dishes. Because KRS has been shown to translocate to the plasma membrane in a laminin-
dependent manner [6] and because KRS suppression did not change laminin expression (Fig. 
1B), we explored the biological significance of KRS expression after reseeding onto laminin 
under reduced (2%) serum-containing conditions. The adhesion-dependent phosphorylation of 
FAK was not abolished by KRS suppression, nor was it affected by treatment with a KRS 
inhibitor [YH16899, which blocks the interaction between KRS and p67LR [7]], when 
compared with KRS-expressing cells (Fig. 2B, lanes 2, 5, 7, and 9). However, the 
phosphorylation of ERK, paxillin, and c-Src in KRS-expressing cells increased upon adhesion 
to laminin and was abolished by additional YH16899 treatment, whereas no effect was 
observed in KRS-suppressed cells (Fig. 1.2B). KRS-dependent FAK activity in 2D 10% serum-
containing normal condition appeared not to be the case when HCT116 cells were manipulated 
to be newly adhered on laminin under a lower serum condition. When the cells were treated 
with the addition of soluble laminin to the culture media, paxillin expression and ERK 
phosphorylation were lower in KRS-suppressed cells than in KRS-expressing cells. We next 
examined the subcellular localization of phospho-ERK or phospho-Tyr118 paxillin in cells 
with various KRS expression levels. When the cells were reseeded onto laminin-precoated 
coverglasses in 2% serum-containing media, KRS-positive (but not KRS-suppressed) cells 
showed obvious phospho-ERK staining in the nucleus (Fig. 1.2C). Phospho-Tyr118 paxillin 
was also clearly localized to focal adhesions in a KRS-dependent manner (Fig. 1.2D). 
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Interestingly, replating cells on laminin for a shorter (2 h) or a longer (24 h) period showed 
phospho-Tyr397 FAK independent of KRS expression, although ERKs phosphorylation and 
paxillin expression and phosphorylation depended on KRS expression (Figs. 1.2E), suggesting 
that FAK activity upon laminin stimulation in 2D condition might not be relevant for KRS 
expression. Given that KRS suppression induced fibronectin (Fig. 1.1B), we also examined 
how the cells would respond to fibronectin simulation. Reseeding KRS-suppressed cells onto 
fibronectin-precoated dishes did not result in any significant difference in Tyr397-
phosphorylated FAK, compared with KRS-expressing cells, although ERK phosphorylation 
depended on KRS expression. Meanwhile, wounds were made in confluent cells in normal 
10% FBS-containing 2D conditions, and KRS-expressing parental cells exhibited clear 
outbound movement at the wound boundary, whereas KRS-suppressed cells did not (Fig. 1.2F). 
These KRS-dependent differential movements toward free spaces might be intrinsically 
correlated with non-effective cell-ECM adhesion for crawling out. 
KRS-dependent dissemination of HCT116 spheroids in 3D collagen I gels 
   Because KRS-expressing (but not KRS-suppressed) cells efficiently moved toward 
free spaces during wound healing, we wondered whether KRS could be important for cell 
dissemination from the tumor masses. In particular, we explored the significance of KRS 
expression in cell dissemination by time-lapse monitoring of HCT116 spheroids (with various 
KRS expression levels) embedded into 3D collagen I gels. Hanging drops of HCT116 cell 
clones with various KRS expression levels efficiently formed spheroids. When spheroids with 
diameters between 70 and 100 m were sieved and embedded into collagen I (2.0 mg/ml) gels, 
the KRS-expressing cells exhibited outbound movement or dissemination of single or as well 
as small groups of cells (Fig. 1.3A, top and bottom panels). However, KRS-suppressed cell 
clones did not show any such dissemination even when monitored for 28 h (Fig. 1.3A, middle 
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panels). Because imaging commenced 3 h after embedding, signaling activities were also 
examined at 3 or 24 h after separate embedding into collagen I gels. Consistent with the 
laminin-adherent 2D condition, c-Src, ERK, and paxillin (but not FAK) activity were similarly 
dependent on KRS expression, decreasing with time after embedding, although only phospho-
Tyr118 paxillin increased as time passed after the embedding (Fig. 1.3B). Decreases in ERK 
and paxillin signaling activities upon KRS suppression were also observed in another colon 
cancer cell line, SW620, in 3D collagen gels (Fig. 1.3C). SW620 cells also showed 
dissemination from spheroids in a KRS expression-dependent manner. Furthermore, KRS-
suppressed cells showed increased mesenchymal markers and decreased epithelial markers 24 
h after embedding (Fig. 1.3D), although they did not disseminate (Fig. 1.3A). The lack of 
dissemination from spheroids by KRS-suppressed cells in 3D collagen I gels might be related 
to an incomplete EMT. Consistent with the absence of outbound movements and lack of 
scattering in 2D conditions (Fig. 1.1), no dissemination from or cell scattering of spheroids in 
3D collagen I gels was observed, although the cells showed reduced E-cadherin at cell-cell 
contacts (Fig. 1.3E). When one epithelial marker (cytokeratin 14, K14) was immunostained in 
the spheroids in 3D collagen I gels, KRS-expressing parental or KRS-overexpressing cells were 
positive for K14 staining in cells at the dissemination margins, whereas KRS-suppressed or 
U0126- or YH16899-treated parental cells were negative for K14 (Fig. 1.3F), suggesting a role 
for K14 in dissemination. Furthermore, ERK phosphorylation and paxillin expression in KRS-
expressing parental HCT116 spheroids in 3D collagen I gels were also decreased by KRS-
suppression (Figs. 1.3G and H). Meanwhile, KRS suppression did not alter other focal adhesion 
molecules such as vinculin, talin, and tensin 2 expression and talin phosphorylation levels but 
decreased vinculin and tensin 2 phosphorylations (Fig. 1.3I), suggesting specific effects on 
paxillin expression and FA molecule phosphorylations via KRS suppression. These 
observations indicate that KRS-mediated dissemination appears to involve cell-cell adhesion 
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properties, as well as cell-ECM adhesion signaling for ERK activity and paxillin 
expression/activity-mediated phosphorylations of FA molecules. 
KRS/p67LR/integrin a6β1 linkage correlates for ERKs activation 
   Because KRS-suppression decreased ERK phosphorylation, we attempted to measure 
the in situ ERK activity using an ERK biosensor. On laminin-precoated coverglasses in 2% 
serum-containing media, KRS-expressing parental or KRS WT-overexpressing cells showed 
greater FRET signals, indicating highly active ERK with activity oscillations, compared to 
KRS-suppressed cells, which showed gradual declines (Figs. 1.4A). This KRS-dependent ERK 
activation was consistent with the observation that ERK phosphorylation was increased by 
KRS overexpression (Fig. 1.2A). Comparising of the mean FRET signal intensities showed 
that ERK activity clearly depended on KRS expression (Fig. 1.4B). Interestingly, transient 
transfection of ERK1 or 2 into KRS-suppressed cells resulted in somewhat increased paxillin 
expression and Tyr118 phosphorylation, but not FAK Tyr397 phosphorylation, in addition to 
dramatically increased phospho-ERK levels (Fig. 1.4C). This observation suggests the 
presence of a link between pERK and paxillin expression/phosphorylation in KRS-expressing 
cells. Given that KRS expression led to ERK phosphorylation, we examined how ERK could 
be activated through KRS. KRS can translocate to the plasma membrane after Thr52-
phosphorylation-dependent disassociation from cytosolic MSC and associate and collaborate 
with p67LR in the presence of laminin [6]. Different HCT116 cell clones with various KRS 
expression levels did not show altered laminin, p67LR, or integrin 6, 1, and 4 expression 
levels (Fig. 1.1B). Integrin 61 and 64 are responsive to laminin and are known to bind 
p67LR [8, 9]. Furthermore, integrins are well-known to activate ERK for different cell 
functions in many cell and tissue systems [14]. Therefore, to determine whether the interaction 
between KRS, p67LR, and integrin 61 could be correlated to ERK activation, we examined 
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possible physical interactions between these proteins via coimmunoprecipitation. Myc-KRS 
prepared from normal 10% FBS-containing culture conditions co-precipitated with integrin 6 
and p67LR, and this interaction was reduced by anti-KRS inhibitor (YH16899) treatment (Fig. 
1.4D). To further analyze the significance of laminin stimulation for this association, myc-KRS 
immunoprecipitates were prepared from cells kept in suspension or reseeded onto laminin-
precoated dishes in culture media containing 2% FBS. Whereas p67LR was shown to bind to 
KRS in lysates from suspended cells, KRS binding to integrin 6 and 1 was observed to be 
adhesion-dependent, and was disrupted by additional treatment with YH16899 (Fig. 1.4E). 
Those molecules including KRS, laminin, p67LR, and integrin 6 were positively correlated 
around the invasive marginal area of breast tumor tissues from the PyVT mouse model (Fig.1. 
4F).  We then examined how ERK activity could be related to paxillin levels. First, we found 
that c-Jun expression and Ser63 phosphorylation, but not Elk-1, p38, or JNKs expression and 
phosphorylation, were correlated with KRS expression (Fig. 14G). In addition, the suppression 
of Elk-1, an ERK-mediated transcription factor, did not down-regulate paxillin expression and 
Tyr118 phosphorylation (Fig. 1.4H). Thus, we speculated that c-Jun might be involved in ERKs 
activity-mediated paxillin expression in a KRS-dependent manner. We therefore examined 
whether ERK activity could be linked to paxillin transcription via c-Jun by chromatin 
immunoprecipitation approaches. Promoter regions that bind c-Jun (Region 1 with two putative 
binding sites at -380 or -460 base pairs upstream of the starting point +1, and nonbinding 
control Region 2) or Elk-1 (putative binding sites at CG-enriched -10 base pair and -498 base 
pair for Region 3 and nonbinding control Region 4) following ERK activation were identified 
(Fig. 1.4I). Chromatin immunoprecipitated with anti-c-Jun, but not normal IgG, showed a PCR 
product for the PXN promoter region, which was abolished in KRS-suppressed or YH16899-
treated HCT116 cells (Fig. 1.4J). Meanwhile, Chromatin immunoprecipitated with anti-Elk-1 
did not show any amplified PCR product (Fig. 1.4K), indicating that ERK activated in KRS-
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expressing cells may transcriptionally induce paxillin via c-Jun rather than Elk-1. In addition 
to HCT116 cells, other colon cancer cells showed decreases in ERK and paxillin activities and 
paxillin expression upon YH16899 treatment (Fig. 1.4L), suggesting that this signaling axis 
depends on the compound to regulate the interaction between KRS, p67LR, and integrin 61. 
Furthermore, in the PyVT breast tumor mouse model, staining of the invasive marginal area 
showed a positive relationship for these signaling molecules (Fig. 4M). Therefore, the 
interaction between KRS and integrin 61 via p67LR may be correlated with KRS 
expression-mediated ERK activity and paxillin expression/activity during dissemination from 
cell masses.  
KRS-dependent cell dissemination require ERKs and paxillin phosphorylations 
   We then explored whether KRS-dependent ERK activation was important for 
dissemination. KRS-expressing parental HCT116 spheroids exhibited the dissemination of 
single cells or cell groups, and this was not observed when the spheroids were embedded in the 
presence of a MEK inhibitor (U0126, leading to ERK inhibition) or YH16899 [to block the 
interaction between KRS and p67LR, as shown in Figs. 4D and 4E and in a previous study [7], 
Supplementary movie 14], although outbound processes or spikes still formed (Figs. 1.5A). 
Treating SW620 cells with U1026 or YH16899 also blocked dissemination. Furthermore, the 
L142A KRS mutant, which does not interact with p67LR [6], caused decreased ERK activity 
and paxillin expression and Tyr118 phosphorylation and did not cause dissemination, much 
like KRS suppression. In addition, whereas EGF treatment of KRS-expressing parental or 
KRS-overexpressing cells showed more dramatic dissemination, KRS-suppression-inhibited 
dissemination was not recovered by exogenous EGF treatment, indicating that growth factor-
mediated ERKs activation might not be sufficient for dissemination under KRS-suppressed 
conditions. Being consistent, EGF treatment-mediated ERK and Elk-1 (but not c-Jun) activities 
20 
 
could not be linked to paxillin induction in KRS-suppressed cells. Therefore, these 
observations suggested that the complex formed by KRS, p67LR, and integrin 61 upon cell-
laminin adhesion might also be important for ERKs activation for dissemination. Treating 
KRS-expressing cells with either U0126 or YH16899 decreased both paxillin and E-cadherin 
mRNA levels (Fig. 1.5B). Each inhibitor decreased ERK phosphorylation, and paxillin 
expression and phosphorylation without activating caspase 3 and resulted in the loss of 
epithelial markers (Figs. 1.5C and D). These inhibitor-mediated effects were very similar to the 
effects of KRS suppression (Figs. 1.1B, 1.3C, and 1.3D). Meanwhile, YH16899 treatment of 
KRS-expressing cells did not result in changes in focal adhesions containing Tyr397-
phosphorylated FAK or in cellular morphology (Fig. 1.5E) but decreased phospho-ERK (Fig. 
1.5F) and phospho-Tyr118 paxillin under 2D laminin-precoated conditions (Fig. 1.5G) or 
phospho-ERK in 3D collagen I gels (Fig. 1.5H). YH16899 or U0126 treatment decreased 
paxillin protein levels in KRS-suppressed cells in 3D collagen I gels (Fig. 1.5I). Interestingly, 
U1026 or YH16899 treatment also decreased the K14 epithelial protein that was localized 
along the outbound dissemination (Fig. 1.5J). Furthermore, it was tested whether the lack of 
dissemination in KRS-suppressed cells might be attributed to no protease activity in these cells. 
MT1-MMP-transfection in KRS-suppressed cells did not cause dissemination, although MT1-
MMP transfected cells were disseminated from parental HCT116 spheroids (Fig. 1.5K, upper 
panels). However, the treatment of U0126 and YH16899 blocked the dissemination of parental 
cells even after MT1-MMP transfection (Fig. 1.5K, lower panels). Thus, the lack of 
dissemination in KRS-suppressed cells might be irrelevant to MMP-based proteolytic activity. 
These observations therefore suggest that the KRS-dependent dissemination of HCT116 




KRS-suppression-inhibited dissemination is recovered by ERK1 and/or paxillin expression 
   We explored whether ERK activity in KRS-expressing cells depended on FAK. 
Because KRS-dependent ERK activity appeared to occur via the formation of a signaling 
complex between KRS, p67LR, and integrin 61, we examined whether and how functionally 
blocking of integrin 6 affected the phosphorylation of FAK and ERK. When HCT116 parental 
cells were preincubated with neutralizing anti-human integrin 6 antibodies, ERK activity that 
was dependent on cell adhesion to laminin for 24 h decreased, as did paxillin expression and 
Tyr118 phosphorylation, but not FAK phosphorylation (Fig. 1.6A). To examine whether FAK 
was important for dissemination, we examined the correlation between FAK activity, ERK 
activity, and paxillin expression and activity downstream of KRS. First, the expression of 
kinase-dead (R454) FAK in KRS-expressing cells decreased FAK phosphorylation, but not 
ERK activity, paxillin expression or Tyr118 phosphorylation (Fig. 1.6B, lanes 1 and 2). In 
addition, the expression of active FAK [N-terminal deleted FAK [15]] or wild-type FAK in 
KRS-suppressed cells increased FAK phosphorylation, but did not alter ERK activity or 
paxillin expression and Tyr118 phosphorylation (Fig. 1.6B, lanes 3 to 8). The lack of a link 
between FAK and ERK/paxillin activity and expression downstream of KRS was also observed 
for the dissemination of cells from spheroids in 3D collagen I gels; although R454 FAK 
expression in KRS-expressing cells did not significantly block dissemination, expressing active 
FAK in KRS-suppressed cells also did not cause dissemination (Fig. 1.6C). In addition, L37A 
mutant FAK, which is shown to be active [15], was stably transfected into KRS-suppressed 
cells. The expression of L37A FAK did not cause ERK activation, paxillin expression or Tyr118 
phosphorylation or dissemination (Fig. 1.6C). These experiments suggested that KRS-
dependent dissemination might involve FAK-independent ERK activation.  Because KRS-
dependent cell dissemination was inhibited by ERK inhibition and because pERK might induce 
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paxillin expression, we examined whether the inefficient dissemination of KRS-suppressed 
cells in 3D collagen I gels could be recovered by the overexpression of ERK1 alone, paxillin 
alone, or both together. Stable transfection of ERK1 resulted in ERK activation, and a slight 
induction of paxillin expression and Tyr118 phosphorylation (Fig. 1.6D), as shown also in Fig. 
4C. In addition, stable transfection of paxillin alone or together with ERK1 resulted in 
moderately increased Tyr118 phosphorylation in paxillin (Fig. 1.6D). The stable transfection 
of ERK1 alone, paxillin alone, or both together caused the KRS-suppressed cell clones to 
undergo dissemination from the spheroids (Fig. 1.6E). Therefore, the blockade of 
dissemination in KRS-suppressed cells may be due to decreased ERK and paxillin activity in 
these cells. 
KRS appear to play pro-metastatic roles at the invasive margins of KRS-/+ mouse breast 
tumor and human colon tumor tissues 
  Next we explored the roles of KRS in lung metastasis of breast tumors using KRS-
heterozygous MMTV-PyVT mice. To generate the KRS genetrap mouse, a genetrap cassette 
was inserted into intron 13 to disrupt KRS gene expression. A comparison of KRS immunoblots 
in various organs from wild-type and heterozygous mice demonstrated the overall reduction of 
KRS. When breast tumor sections in PyVT mice were stained with hematoxylin-eosin or 
immunostained for KRS, the compact core region of the tumor section showed very weak KRS-
staining, whereas marginal regions with highly complex lumen structures showed strong KRS-
staining (n = 4, Fig. 1.7A). KRS-heterozygous PyVT mice showed a lower incidence of 
metastasis than KRS wild-type mice, as determined by counting metastatic lung nodules in the 
PyVT mice (TG) with the indicated krs genotype at 16 or 18 weeks of age (Fig. 1.7B). 
Therefore, this KRS-/+ mouse model suggested that KRS might play important roles at the 
invasive margins of tumor masses. We then examined the correlation between KRS, pERK, 
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and paxillin in clinical colon cancer tissues. Compared with normal colon tissues from colon 
cancer patients, tumor tissues showed higher KRS and paxillin expression (7/7, Fig. 1.7C), 
suggesting a positive correlation between KRS and paxillin, which support the KRS-mediated 
metastatic dissemination phenotypes as well as the positive staining of invasive margins in 
KRS-/+ mouse tumor models. Interestingly, pERK was not easily detected to access the 
correlation with KRS or paxillin expression in either normal or tumor colon tissue extracts (Fig. 
1.7C), presumably because the extracts were from mixed populations of different cell types 
around the tumor lesions. Furthermore, an online database (i.e., Oncomine, 
www.oncomine.org) showed a positive correlation between the significant overexpression of 
KRS and paxillin in colon carcinoma samples (Fig. 1.7D). Therefore, we examined the 
molecular correlation in serial sections of normal and tumor colon tissues. Tumor tissues 
identified as grade II or III clearly showed marginal and local staining for pERK, whereas KRS 
and paxillin were observed not only in local areas but also in massive core areas (Fig. 1.7E). 
These observations indicated that KRS might mediate ERK and paxillin activation around 







Fig. 1.1. KRS-dependent incomplete EMT phenotypes in normal 2D conditions.  
(A and B) RT-PCR (A) or standard Western blots (B) for the indicated epithelial or 
mesenchymal markers from KRS-expressing parental HCT116 (P), stably myc-KRS wildtype-
overexpressing HCT116 (KRS WT), and stably KRS-suppressed HCT116 cell clones (2-1, 2-
2, 2-3, and 5-4 for shKRS) normally cultured 1n 2D 10% FBS-containing condition. (C) Cells 
were cultured on coverglasses precoated with 10% FBS-containing culture media until 
confluence and then immunostained for E-cadherin or -catenin along with DAPI costaining. 
(D) Subconfluent cells from the normal 2D condition were imaged using a phase contrast 


















Fig. 1.2. KRS suppression impair cell-ECM adhesion and signaling activities.  
(A) HCT116 cells with various KRS expression levels [parental P, KRS-suppressed 2-1 and 5-
4 clones, and myc-KRS WT overexpressed (WT) cells] were analyzed for the indicated 
molecules via standard Western blots. KRS-suppressed cells in normal 2D conditions showed 
decreased FAK, ERKs (A), c-Src, and paxillin phosphorylation, compared with KRS-
expressing cells. (B to D) Cells were kept in suspension (S) or reseeded onto laminin (Ln) -
precoated dishes or coverglasses with DMSO (C) or YH16899 (YH) treatment for 2 h, prior to 
harvesting for standard Western blots for the indicated molecules (B) or immunostaining for 
pERK (C) or Tyr118-phsophorylated paxillin (D) together with phalloidin staining for F-actin. 
(E) Cells were replated onto laminin-precoated culture dishes containing reduced (2%) FBS 
(to make cells healthy while minimizing effects from serum components) for 2 or 24 h, prior 
to immunostaining using anti-Tyr397-phosphorylated FAK (green), phalloidin (red), and DAPI 
(blue) staining. (F) Confluent cells grown under normal 2D conditions were wounded, washed, 
and treated with either DMSO or the indicated inhibitor. Fifteen hours later, cells near the 














Fig. 1.3. Impaired adhesion-related signaling in KRS-suppressed cells correlates to a lack 
of dissemination from spheroids in 3D collagen I gels.  
(A) Spheroids of HCT116 colon cancer cells (parental, stable shKRS-transfectant clones of 2-
1, 2-2, 2-3, and 5-4, and stably myc-KRS WT overexpressing cells) embedded in 3D collagen 
I gels were imaged by time-lapse microscopy for 28 h. Note that KRS-expressing parental and 
myc-KRS WT cells showed dissemination of single cell or small groups of cells from the 
spheroids. (B to D) HCT116 (B and D) or SW620 (C) cells embedded in 3D collagen I gels for 
3 (B) or 24 h (B, C, and D) were harvested for whole-cell extracts prior to performing standard 
Western blots for the indicated molecules. (E) Spheroids of HCT116 parental cells (left) or 
HCT116 shKRS cells (2-1 clone, middle), and HCT116-KRSWT (right) cells embedded in 3D 
collagen I gels for 24 h were double-stained with DAPI (blue) and anti-E-cadherin (green) 
antibody. Note that spheroids in the 3D environment retained their shapes without dispersion. 
(F) Cells were embedded in 3D collagen I gels for 24 h before fixation, permeabilization, and 
immunostaining for K14 (green) in parallel with phalloidin (red) and DAPI (blue) staining. 
Arrow heads depict cells presumably disseminating with K14 expression. (G and H) Cell 
spheroids embedded in 3D collagen I gels for 24 h were immunostained for pERK (G, red) or 
paxillin (H, green), with DAPI (blue) costaining. (I) Cells were embedded in 3D collagen I 
gels for 24 h were harvested and processed for standard Western blots for the molecules. Data 


















Fig. 1.4. KRS-mediated ERK activation correlates with the formation of a p67LR/integrin 
61 complex.  
(A) Cells reseeded onto laminin-precoated cover glasses for 24 h were processed for ERK 
activity analysis using an ERK1 FRET biosensor. (B) The mean fluorescence intensities of 
each cell from separate cell images (n= separately imaged cell numbers) were measured using 
the MetaMorph software and presented as a graph of the mean ± standard deviation (SD) of 
the FRET value/CFP ratio. (C) In addition to KRS-expressing parental (P) and KRS WT-
overexpressing cells, KRS-suppressed cells were transiently transfected with mock (M), 
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paxillin (Px), or ERK1/2 (Ek) expression vectors for 24 h, and then their spheroids were 
embedded into 3D collagen I gels for another 24 h, before harvesting and standard Western 
blotting for the indicated molecules. (D and E) Myc-KRS WT cells grown in normal 2D 
conditions (D), kept in suspension (S), or reseeded onto laminin (Ln)-precoated dishes in the 
presence of DMSO (C) or YH16899 (YH) treatment were harvested for whole cell lysates 
(WCL) prior to immunoprecipitation using normal IgG (IgG) or anti-myc antibody and 
standard Western blotting for the indicated molecules. (F) Serially-sectioned breast tumor 
tissues from PyVT mice were stained for the indicated molecules and visualized at ×200 
magnification. Black-dotted boxes depict the marginal area invasive to mesenchyme. (G and 
H) Subconfluent cells (G) or cells transiently transfected with siRNA against a control 
sequence (siControl) or Elk-1 (siElk-1) (H) were harvested for whole-cell lysates and 
normalized and processed for standard Western blots for the indicated molecules. (I) Schematic 
representation of the promoter regions of the human paxillin gene with putative c-Jun or Elk-1 
binding sites and the PCR amplification region of the chromatin immunoprecipitates. (J and 
K) Chromatin immunoprecipitated from cells using normal IgG or anti-c-Jun (H) or anti-Elk-
1 (I) antibodies without or with U0126 or YH16899 treatment were processed for PCR using 
primers for the PXN promoter regions (5 putative c-Jun binding sites within Region 1, a 
putative binding site in Region 3 for Elk-1) or control regions without binding sites (Region 2 
for c-Jun, Region 4 for Elk-1). Bp depicts the DNA ladders. (L) Subconfluent colon cancer 
cells were treated with DMSO (C) or YH16899 (increasing doses at 50 and 100 M) for 24 h, 
prior to harvesting of whole-cell lysates and immunoblotting for the indicated molecules. (M) 
Immunohistochemistry of PyVT breast tumor tissues with invasive marginal area (boxed) for 



















Fig. 1.5. KRS-dependent cell dissemination from spheroids in 3-D collagen I gels is 
blocked by anti-MEK/ERK U0126 or anti-KRS YH16899 treatment.  
(A) Spheroids of HCT116 parental cells embedded in 3D collagen I gels in the presence of the 
ERK inhibitor U0126 (50 µM) or the KRS inhibitor YH16899 (50 µM) were imaged by time-
lapse microscopy after embedding for 32 h. (B to D) HCT116 parental spheroids in 3D collagen 
I gels were treated with U0126 (50 or 100 µM) or YH16899 (50 or 100 µM) for 24 h, and the 
cells were then processed for RT-PCR for the indicated molecules (B) or harvested for standard 
Western blots, using antibodies against the indicated molecules (C and D). (E and G) Cells 
were reseeded onto laminin-precoated coverglasses for 2 h in the presence of YH16899 (50 
M) treatment before immunostaining for Tyr397 FAK-phosphorylated FAK (E, green), pERK 
(F, green), or Tyr118-phosphorylated paxillin (G, green) with phalloidin for F-actin (red) and 
DAPI for DNA (blue) costaining. (H) HCT116 parental spheroids in 3D collagen I gels were 
immunostained for pERK (red) with DAPI (blue) costaining. (I and J) Spheroids embedded in 
3D collagen I gels for 24 h in the presence of DMSO (vehicle control), U0126, or YH16899 
were immunostained for paxillin together with DAPI staining (I) or the epithelial marker K14 
(green, J) together with F-actin (red) and DAPI staining (I). Right panels are enlarged from the 
red boxes in the corresponding left panels (I). Arrow heads depict cells presumably 
disseminating with K14 expression (J). (K) Cells transiently transfected with mCherry-
conjugated MT1-MMP (red) plasmid were embedded into 3D collagen I for 3 h and then live-
imaged for dissemination in the absence or presence of U0126 or YH16899 treatment. Data 












Fig. 1.6. Blockade of dissemination by KRS-suppression is relieved by ERK and/or 
paxillin expression.  
(A) HCT116 parental cells were suspended in serum-free BSA containing media, preincubated 
with normal IgG or functional anti-human integrin 6 blocking antibody (20 g/ml) for 30 
min, and then kept in suspension or reseeded onto laminin-precoated culture dishes with 2% 
serum-containing media for 2 or 24 h. Whole-cell lysates were immunoblotted for the indicated 
molecules. (B and C) Cells were transduced with adenovirus (Ad-HA) for R454 (kinase dead) 
FAK, ΔN(1-100) FAK, or FAK WT for 12 h, or stably transfected with the L37A FAK mutant. 
The cells were embedded in 3D collagen I gels, and 3 h later, cell lysates were prepared for 
immunoblotting (B) or time-lapse imaging was performed for a further 28 h ( 1:04:00, C). (D 
and E) KRS-expressing cells and KRS-suppressed HCT116 cell spheroids (2-1, 2-3 and 5-4 
clones) with stable transfection of ERK1 (ERK), paxillin (PXN), or ERK1/paxillin (PEE) were 
embedded in 3D collagen I gels for 24 h, prior to harvesting whole-cell lysates for 
immunoblotting for the indicated molecules (A). Alternatively, the spheroids were embedded 
for 3 h and then time-lapse imaged for another 24 h (B). Note that KRS-suppressed cells did 
not disseminate, whereas spheroids with ERK1, paxillin, or ERK1/paxillin overexpression 










Fig. 1.7. Positive relevance in tumor metastasis of KRS in KRS-/+ PyVT mouse and colon 
cancer patient tissues.  
(A) Breast tumor sections of the compact core or marginal region in PyVT mice were stained 
with hematoxylin-eosin (HE, upper panels) or immunostained for KRS (KRS IHC, lower 
panels). (B) Metastatic lung nodules were counted in the PyVT mice (TG) with the indicated 
Kars genotypes (WT or KRS-/+ heterozygosity, Het) at 16 or 18 weeks of age. (C) Serial 
sections (6 μm) from normal (N) or tumor (T) tissues from grade II or grade III colon cancer 
patients were processed for immunohistochemistry using anti-pERK, KRS, or paxillin 
antibodies in addition to controls using normal rabbit (Rb) or mouse (MS) IgG. (D) Data from 
Oncomine online cancer genomics data analysis tools showed the significant overexpression 
of KRS and paxillin in a positively-correlated manner in colon carcinoma, compared with 
normal colon tissues. (E) Normal (N) or tumor (T) colon tissues from different clinical colon 
cancer patients were harvested for whole-tissue extracts at 4ºC, prior to standard Western 
blotting for the indicated molecules. Data shown represent three independent experiments. (F) 
Scheme to represent KRS-mediated cell dissemination from spheroids in 3D collagen I gels 
via regulations of cell-cell and cell-ECM adhesion. Laminin expressed in an autocrine manner 
binds to p67LR, which forms a complex with KRS and integrin 61, leading to ERK 
activation that in turn causes paxillin expression, via c-Jun-dependent transcriptional 
activation, and Tyr118 phosphorylation. Activated paxillin can mediate cell-ECM adhesion-








   The observations in this study, made using diverse systems, such as in vitro cells 
adherent on 2D layers or embedded in 3D collagen I gels, KRS-/+ heterozygous mice, and 
clinical colon tissues, support the notion that KRS functions together with p67LR/integrin 
61 receptors to mediate cell dissemination from (tumor) cell masses via the laminin 
adhesion-dependent regulation of ERK and paxillin expression and activity. During the 
regulation of dissemination, KRS was also involved in regulating cell-cell contacts and cell-
ECM adhesion. The outbound movement or dissemination from the boundaries of KRS-
expressing cell spheroids appeared to be supported by KRS-dependent signaling to facilitate 
outbound crawling upon the adhesion of cells to laminin. ERK activity and paxillin 
expression/activity leading to efficient FA formation and signaling, following the formation of 
a complex between KRS, p67LR and integrin 61, were important for cell dissemination from 
colon cancer spheroids embedded in 3D collagen I gels (Fig. 7F). Inactivating ERK or 
disrupting complex formation blocked dissemination and the reintroduction of ERK or paxillin 
in KRS-suppressed cells restored dissemination. Although FAK-mediated ERK activity in cell 
adhesion is well known [16] and KRS-expressing A549 cells activate FAK upon being reseeded 
on laminin [6], here FAK appears not to paly importantly in the 3D dissemination of HCT116 
cells. KRS-suppressed HCT116 cells showed still detectable FAK activity, whereas KRS-
overexpressed HCT116 cells showed more FAK activity than parental HCT116 cells, indicating 
a correlation between KRS and FAK might be valid only when KRS is highly expressed. 
Furthermore, FAK activity was not relevant for KRS-dependent ERK activation and 
dissemination. This KRS/ERK/paxillin signaling axis was implicated in marginal invasiveness 
and metastasis in mouse animal and in clinical colon tissue models. This study provides further 
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evidence of a platform for KRS-dependent cell dissemination from tumor masses in 3D 
collagen I gels, which may be useful to screen anti-metastatic reagents against KRS-dependent 
colon cancers. 
   This study revealed that KRS was involved in the regulation of cell-cell contacts as 
part of its pro-metastatic functions. However, such a role for KRS has never been explored. 
Here, we observed that whereas KRS suppression (to certain levels) did not cause any apoptotic 
caspase 3 activation, KRS suppression modulated the epithelial-mesenchymal properties of 
cells; KRS suppression decreased the expression of epithelial markers (i.e., E-cadherin, -
catenin, ZO1, etc.) and concomitantly increased mesenchymal markers (i.e., Vimentin, N-
cadherin, Twist, Snail1, etc.), although it is not currently known how KRS causes these 
alterations. However, KRS suppression did not cause cell scattering, supporting an incomplete 
EMT phenotype in KRS-suppressed cells, and indicating that KRS-suppressed cells retained 
certain characteristics of epithelial cells that prevent them from scattering. Furthermore, the 
lack of proteolytic activity of MMPs such as MT1-MMP appeared not to be the cause of no 
dissemination in KRS-suppressed cells. KRS-suppressed cells could not move outbound or 
disseminate from the boundaries of cell masses, presumably because losses of epithelial 
markers would not be all enough for the outward movement or dissemination, with further cell-
ECM adhesion capacity also being required for these processes. Consistent with this 
hypothesis, cells disseminating from spheroids in a KRS-dependent manner were positive for 
the epithelial marker K14, although its role in dissemination as an epithelial marker protein 
remains to be explained. 
   We observed that KRS-dependent dissemination might not depend solely on either 
epithelial or mesenchymal characteristics; KRS-suppressed cells could not efficiently 
disseminate from cell masses in either 2D or 3D conditions, although they obviously lost E-
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cadherin and other epithelial markers. It is well established that circulating tumor cells (CTCs) 
originating from primary breast tumors consist of cells with epithelial, mesenchymal, or both 
characteristics [1, 17]. The EMT is a key process that results in morphological changes and 
altered adhesion characteristics and is crucial to the metastasis of CTCs [18]. Several previous 
studies have examined biomarkers from colorectal cancers (CRCs)-derived CTCs, which 
include hepatocyte growth factor receptor c-Met, melanoma antigen gene-A3 family 
(MAGEA3), 1-4-N-acetylgalactoaminyltransferase (GalNAc-T), and cytokeratin-20 (CK20) 
[19], or human telomerase reverse transcriptase (hTERT), cytokeratin-19 (CK19)/cytokeratin-
20 (CK20), and carcinoembryonic antigen (CEA) [20]. In these reports, CTCs derived from 
colorectal cancer cells could commonly be marked by CK20, which is a typical epithelial 
marker, suggesting that epithelial characteristics may also be at least somewhat important for 
metastasis, presumably by playing roles during colonization and proliferation at secondary 
metastatic sites. Therefore, it may be likely that KRS-expressing cells with certain epithelial 
characteristics resulted in dissemination for eventual metastasis. 
   In addition to regulating cell-cell adhesion, KRS was involved in the regulation of cell-
ECM adhesion as part of its pro-metastatic functions. KRS translocates from the cytosolic MSC 
to the plasma membrane after p38 MAPK-dependent Thr52 phosphorylation upon extracellular 
laminin stimulation, where it protects p67LR from ubiquitination-mediated degradation [6]. 
Furthermore, the interaction between KRS and p67LR is critically involved in the lung 
metastasis of subcutaneously-injected mouse breast carcinoma 4T1 cells with KRS 
overexpression [7]. We observed here that the KRS/p67LR complex also included integrin 6, 
allowing KRS-expressing cells to transduce intracellular signals under extracellular laminin-
stimulated conditions. Although the 3D culture in this study was performed using collagen I 
gels supplied with 10% FBS-containing culture media, cells efficiently expressed laminin 
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independent of KRS expression, suggesting that laminin was available during the experiments 
in the 3D collagen I gels. Interestingly, KRS-suppressed cells expressed more fibronectin, and 
their adhesion onto fibronectin still caused similar or slightly reduced adhesion-related FAK 
phosphorylation but decreased ERK phosphorylation compared with KRS-expressing cells on 
fibronectin. Moreover, extracellular laminin but not collagen I causes KRS translocation to the 
plasma membrane for binding to p67LR [6]. Thus, it is likely that KRS may mediate ERK 
activation for pro-metastatic roles following specific signals from the extracellular 
microenvironment, including laminin. Consistent with this role, KRS expression around the 
invasive margins in animal or human cancer tissues was correlated with laminin and p67LR 
expression. 
   Within laminin-containing 3D collagen I gels, KRS mediated ERK and paxillin 
activations. FAK, SFKs, paxillin, and ERK1/2 are key regulators of focal adhesion dynamics, 
especially during cell adhesion and migration [21, 22]. Cell-ECM adhesion activates ERK, via 
a FAK Tyr925 phosphorylation-mediated signaling pathway from FAK to the Ras cascade upon 
integrin/ECM engagement [16]. FAK-independent ERK activation is also possible upon cell 
adhesion; the association of integrins with caveolin-1 and Fyn (a c-Src family kinase member) 
recruits Shc for ERK activation [23-25]. Furthermore, the cell adhesion-dependent activation 
of CaMKII in vascular smooth muscle (VSM) cells leads to ERK activation independent of 
FAK activity [26]. 
  Meanwhile, FAK phosphorylation in 3D collagen I appeared not to support KRS-
dependent dissemination in this study, and KRS was not correlated with FAK/c-Src 
phosphorylation upon cell adhesion to laminin or embedding in 3D collagen I gels. We 
observed that YH16899 inhibitor treatment to block the binding of KRS to p67LR resulted in 
decreased formation of the KRS/p67LR/integrin 61 complex, the phosphorylation of ERK, 
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and the dissemination of HCT116 parental cells. Functionally blocking integrin 6 to prevent 
ERK activation during laminin adhesion by KRS-expressing cells still maintained efficient 
FAK activity. Transduction of WT or active FAK adenovirus or stably transfecting active L37A 
FAK [15] into KRS-suppressed cells did not rescue ERK activity, paxillin expression/activity, 
or the dissemination of KRS-suppressed cells. KRS was also previously shown to be 
phosphorylated at Ser209 or Thr52 by either ERK for nuclear translocation [5] or p38MAPK 
for plasma membrane localization [6], respectively. However, KRS-mediated intracellular 
signal transduction has not been explored any further. KRS expression was shown to cause 
ERK phosphorylation/activity by several approaches in this study: (a) the overexpression of 
KRS caused ERK phosphorylation even in suspended cells: (b) cell adhesion-dependent ERK 
phosphorylation depended on KRS expression: (c) in situ ERK activation upon reseeding onto 
laminin was observed using a FRET ERK biosensor approach: (d) KRS-dependent biological 
behaviors, including dissemination from the cell masses, were blocked by ERK inhibition: and 
(e) overexpressing ERK1 rescued the dissemination of KRS-suppressed cells.In this study, 
KRS-dependent ERK activity was positively correlated with expression and phosphorylation 
of paxillin, vinculin and tensin 2, but not of other focal adhesion molecules, indicating that 
KRS suppression-mediated effects on paxillin (expression and activity) led to secondary effects 
on other FA molecule phosphorylations. Although paxillin is known to be phosphorylated by 
active FAK [27], this study further revealed that paxillin expression was regulated by ERK 
activity, because (a) ERK overexpression in KRS-suppressed cells enhanced paxillin 
expression and Tyr118 phosphorylation: (b) pharmacological ERK inhibition decreased 
paxillin expression and phosphorylation: and (c) chromatin immunoprecipitation showed that 
downstream of active ERK, c-Jun bound to the promoter region, presumably to regulate 
paxillin transcription, in a KRS inhibitor-dependent manner. It was also previously shown that 
activated ERK correlated with total paxillin expression and Ser178 phosphorylation but not 
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with Tyr118 phosphorylation during EGF/TGF1-mediated hepatocyte migration [28]. Paxillin 
localizes to focal adhesions, which are the structure in which adhesion receptor integrins bind 
extracellular matrix proteins such as laminin [29]. This linkage from the KRS/p67LR/integrin 
61 complex to paxillin expression/phosphorylation via ERK/c-Jun activity could thus be the 
underlying mechanism by which KRS regulates cell-ECM adhesion and dissemination 
presumably as a pro-metastatic molecule. Therefore, KRS may represent a promising 









Lysyl-tRNA synthetase (KRS) promotes dissemination from colon cancer 
spheroids via recruitment and reprogramming of macrophages in 3D 













   It is well established that tumor microenvironment plays an important role in cancer 
development and metastasis. Cell-cell and cell-substrate adhesion properties of cancer cells can 
be targeted to block cancer metastasis. Although cytosolic lysyl-tRNA synthetase (KRS or 
KARS) canonically functions in protein synthesis, it is reported that KRS on the plasma 
membrane is involved in cell migration/invasion and cancer metastasis. We found that KRS-
positive cells in 3D collagen I gels showed clear disseminative phenotypes from cancer 
spheroids, whereas KRS-suppression was enough to block the phenotype. It is reasonable that 
the close vicinity of cancer cells and tumor-associated macrophages (TAMs) at the invasive 
front of tumors suggests that these two cell types may mutually interact leading to a promotion 
of KRS-mediated cell migration/invasion and cancer metastasis. Analysis of cytokines secreted 
by KRS-positive spheroids showed a greater secretion of cytokine GAS6 than KRS-negative 
spheroids, which caused polarization of macrophages from M1 to M2 population. Nucleus 
KRS upregulated expression of GAS6 mRNA through MiTF to bind the promotor region of 
GAS6. This KRS-mediated cancer cell dissemination appeared to be depending on the role of 
nucleus KRS to cause the expression of cytokine (including GAS6) for M2 polarization and 
also membraneous KRS to cause intracellular signaling linkage for cell-ECM engagement-
mediated tractive force generation, as explained in the chapter 1. In return, the treatment of 
conditioned media (CM) from M2 macrophage to cancer spheroids caused a greater 
dissemination from KRS-positive spheroids, and a recovery of the disseminative phenotype 
even from KRS-negative spheroids, which was to a degree less than those from KRS-positive 
spheroids. FGF2/GRO-/M-CSF in the conditioned media of M2 macrophage mediated 
activation of intracellular signaling pathways that involved paxillin, ERKs, STAT3, and NF-
B in cancer cells to cause disseminative phenotypes. Therefore, KRS-positive cancer cells 
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appeared to cause macrophage infiltration and M2 polarization, which then supported for 
disseminative invasion of (KRS-negative and/or positive) cancer cells. Normal fibroblasts 
appeared to be differentiated to CAFs (cancer-associated fibroblasts) by treatment of M2 
macrophage CM, and CAFs induced laminin and thereby dissemination/migration of KRS-
positive cancer cells presumably under the laminin-containing microenvironment, as shown in 
the chapter 1. Altogether, the KRS-positivity in colon cancer cells allow metastatic cells to 
efficiently gain functions at the cancer-stromal interface, suggesting that KRS can be a 


















Tumor microenvironment plays a pivotal role in tumor progression and metastasis, and 
there are a variety of cells that help cancer cells, including cancer cells [30, 31]. Among them, 
tumor-associated macrophages (TAM) are the most notable, and many studies have been 
reported recently. Correlation of poor prognosis and TAM in various types of cancer, including 
colorectal cancer have been showed many studies and clinical evidence [32]. Macrophages 
differently respond to a variety of microenvironmental signals, and therefore have different 
functions depending on the microenvironment [33]. Recent studies have shown that 
macrophages can undergo significant phenotypic changes due to their diverse interactions with 
tumor cells, by entering the tumor microenvironment and then retain its character. It is usually 
described in two phenotypes depending largely on the characters of the macrophage; M1 
(classically activated) macrophages that produce pro-inflammatory cytokines are strong 
inhibition factor of pathogens and tumor cells, and M2 (alternatively activated) macrophages, 
which produce a large amount of anti-inflammatory cytokines, show anti-inflammatory effects 
[34, 35]. In malignant tumors, TAM is mostly similar to the M2 phenotype, but the exact 
phenotype and characters are still unclear [36]. It has been shown that TAM promotes the 
progression and metastasis of colorectal cancer by secretion of a variety of cytokines. TAM-
derived cytokines can promote migration and invasion of cancer cells by increasing cell- 
extracellular matrix (ECM) interaction in the tumor microenvironment [37, 38]. 
Where TAM is usually found, it has been reported that it is often observed in the 
invasive portion of advanced tumors [39]. It has already been studied that the expression of 
KRS is high in invasive cancer tissues, and therefore the relationship between TAM and cancer 
cells with high expression of KRS can be expected [40]. Previous studies have shown that 
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cancer cells with high expression of KRS are advantageous for metastasis, suggesting that such 
KRS-expressing cancer cells can regulate tumor microenvironment and thus have a selective 
advantage in migration [7]. In this study, we present a fundamental mechanism for studying 




















1. Cells.  
  Human colon cancer cell lines HCT116, SW620 and mouse colon carcinoma CT-26 
cells (American Type Culture Collection, Manassas, VA, USA) were stably transfected with 
shRNA against KRS (transcript 1, NM_001130089, lysyl-tRNA synthetase MISSION® 
shRNA Plasmid DNA, Sigma). DNA construct (in PLKO.1 lentiviral vector backbone) was 
isolated from bacterial culture. Lentiviral production was performed by transfection of 
HEK293T cells using Fugene 6 (Promega). Supernatants were collected 24–48 h after 
transfection and then filtered through 0.22-mm syringe filter. Cells were infected with lentivirus 
with 8 mg ml-1 polybrene for 24 h and then the medium was replaced with fresh growth media 
containing puromycin (1–2 mg ml-1) for selection. HCT116 cells overexpressing KRS were 
established via the stable transfection of a myc-tagged KRS plasmid [6]. The cDNAs encoding 
Myc-KRS mutants at S207A were cloned using a QuikChange II kit (Agilent Technologies, 
Santa Clara, CA, USA) following the manufacturer’s instruction. Other HCT116 KRS mutant 
stable cell lines(ΔC5, T52A) were kindly provided by Dr. Sunghoon Kim (Seoul National 
University, Seoul, Korea). Stable myc-tagged KRS and different stable shKRS-transfected 
clones were established by using 250 g/ml G418 or 0.50 g/ml puromycin (AG Scientific, 
Inc., San Diego, CA). The cells were maintained in RPMI-1640 (WelGene, Daegu, Korea) 
containing 10% FBS and antibiotics (Invitrogen, Grand Island, NY, USA). Human monocyte 
THP-1 cells were kindly provided by Dr. Mi-Ok Lee (Seoul National University, Seoul, Korea). 
THP-1 cells were differentiated by treatment with 100 nM phorbol-12-myristate-13-acetate 
(PMA) for 1 day. The adhered cells were further differentiated with 100 ng/ml 
lipopolysaccharide for 72 h and 20 ng/ml IFN-γ during the last 72 h (M1) or 20 ng/ml IL-4 and 
20 ng/ml IL-13 for 72 h (M2). Fibroblasts from normal colon CCD-18CO were obtained from 
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American Type Culture Collection (ATCC) and grown according to standard protocols. Human 
monocytes from the peripheral blood of healthy donors were kindly provided by Dr. Eun-
Kyung Jo (Chungnam National University, Daejeon, Korea). 
2. Animals 
  Balb/c mice and C57BL6 mice, 10 weeks of age, were purchased from Orient 
Bio,KOREA.  All care administered to the animals was in accordance with protocols 
approved by the Seoul National University Institutional Animal Care and Use Committee. 
Colorectal cancer was induced using the protocol described by [41] with slight modifications. 
. In brief, BALB/c mice or C57BL6 mice were intraperitoneally administered azoxymethane 
(AOM) to initiate colon carcinogenesis. And then, mice were given two cycles of dextran 
sodium sulfate (DSS) in drinking water, in which each cycle consisted of one week of DSS 
water followed by two weeks of tap water. Experiments were performed with 8-week-old 
female Balb/c mice. CT-26 cells were harvested, washed three times in phosphate-buffered 
saline and resuspended in sterile phosphate-buffered saline at a cell concentration of 1 × 
105/200 μl. Cells were injected into mouse tail veins using a 25-gauge needle. (n = 5 per group, 
2 groups). At days 21, mice were sacrificed, and peritoneal tumors were histologically 
examined. 
3. Spheroid formation and embedding into 3D collagen I gels 
  HCT116, SW620 and CT-26 cells with modulated KRS expression levels, or other 
colon cancer cells were processed for spheroid formation using Petri dishes on rotary orbital 
shakers or Perfecta3D® 96-well hanging-drop plates (3D Biomatrix, Ann Arbor, MI). 
Spheroids were selected to be less than 70 μm in size using a cell strainer sieve (SPL Life 
Science Co., Pocheon-si, Korea) prior to being embedded into 3D collagen I gels (BD 
Biosciences, San Jose, CA, USA). For embedding, polydimethylsiloxane (PDMS) chambers 
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with an 8-mm diameter, or 10 well-slips for 22 x 60 mm coverslips (model No.: WL-2260-10, 
Live Cell Instrument, Seoul, Korea), were filled with 70 l collagen I (2.0 mg/ml, BD 
Biosciences) to coat the bottom surfaces of the chamber. PDMS (Sylgard 184, Dow Corning, 
Midland, MI) prepolymer was prepared using a 10:1 (w/w) mixture of PDMS base and curing 
agent, cast against the master and thermally cured to obtain a negative replica-molded piece. 
Spheroids were then mixed with ice-cold collagen I solutions (2.0 mg/ml), which were prepared 
by diluting a concentrated collagen I (BD Biosciences) stock with 10 × reconstitution buffer 
(260 mM sodium bicarbonate and 200 mM HEPES), and 10 × RPMI-1640 with phenol red 
[11]. The pH was adjusted in the range of 7.2 to 7.4 using ice-cold 2 N NaOH. The mixture 
was transferred to a 37ºC CO2 incubator to allow the collagen I to polymerize and form a 
fibrillar meshwork. The 3D culture was then refreshed each day with standard culture media 
containing 10 % FBS. 
4. Extract preparation and Western blots.  
  Colon cancer cells within collagen I gels were washed with ice-cold PBS and then 
homogenized with truncated pipette tips (3 times × 20 min on ice) in modified RIPA buffer (50 
mM Tris-HCl, 150 mM NaCl, 1% NP-40, and 0.25% sodium deoxycholate) with a protease 
inhibitor cocktail (GenDepot, Barker, TX). The extracts were centrifuged for 30 min at 15,000 
g and 4°C, and then the lysates were collected from the supernatant. The protein amounts were 
normalized with the band intensities for -tubulin or -actin via standard Western blots, before 
further immunoblotting with different antibodies. The primary antibodies used in the study 
were as follows: -SMA (Sigma, St Louis, MO); Hsp90, pY701STAT1, pY705STAT3, STAT6, 
pY641STAT6, ERKs, phospho-ERKs, pY845EGFR and phospho-FGFR(pY653/654) (Cell 
Signaling Technol. Danvers, MA); paxillin (BD Biosciences); p67LR, laminin, p-
MerTK(pY749/753/754) and MiTF (Abcam, Cambridge, UK); pY118paxillin, E-cadherin, 
59 
 
IBSTAT1STAT3, CXCR2, M-CSF, FGFR1, FGFR2, Axl, Histone H1, angiogenin, c-
Myc, -actin and -tubulin (Santa Cruz Biotech., Santa Cruz, CA); integrin v1, (Millipore, 
Billerica, MA); Gas6, phospho-Axl, MerTK (R&D systems) EGFR (Thermo) and KRS 
(Neomics, KOREA).  
5. Time-lapse imaging of cells in 3D ECM gels.  
  Various stable cell lines were processed for spheroid formation using Petri dishes on 
rotary orbital shakers or Perfecta3D® 96-well hanging-drop plates (3D Biomatrix, Ann Arbor, 
MI). One hour after spheroids were embedded in 3D collagen I gels, time-lapse images were 
collected for the indicated periods using IX81-ZDC microscope (Olympus, Tokyo, Japan). The 
microscope was equipped with a 10-well Chamlide Incubator system (Live Cell Instrument, 
Seoul, Korea), and an environmental chamber mounted on the microscope maintained constant 
conditions of 37°C, 5% CO2, and 95% humidity.  
6. Coimmunoprecipitations.  
Whole-cell extracts prepared from cells in standard media containing 10% FBS were 
immunoprecipitated overnight using anti-myc tag antibody-coated agarose beads (Sigma). The 
immunoprecipitated proteins were boiled in 2 × SDS-PAGE sample buffer before standard 
Western blot analysis. 
7. Indirect immunofluorescence.  
  Human normal colon fibroblast CCD-18CO embedded in 3D collagen I gels within 
PDMS were immunostained using antibodies against α-SMA, laminin in addition to DAPI 
staining for the nucleus. Immunofluorescence images were acquired on a confocal laser 
scanning microscope with a Nikon Plan-Apochromat 60×/1.4 N.A. oil objective (Nikon eclipse 
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Ti microscope, Nikon, Tokyo, Japan). 
8. Chromatin immunoprecipitation (ChIP).  
ChIP assays were performed using the ChIP-IT Express kit (Active Motif, Carlsbad, 
CA), following the manufacturer’s protocols. Briefly, cells seeded in a plate for 48 h were fixed 
for 10 min with fixation solution, and the chromatin was then prepared by sonication shearing 
to aid nuclear release and enzymatic shearing. The sheared chromatin was immunoprecipitated 
using MiTF (Abcam) or c-Jun (Cell Signaling) antibodies and captured with protein G 
magnetic beads. The chromatin was eluted from the purified immunoprecipitates, reversed 
cross-linked, and digested with proteinase K. The reaction was then stopped using proteinase 
K stop solution. The isolated chromatin was analyzed by 36 cycles of PCR. Ten microliters of 
each PCR product was separated via 2% agarose electrophoresis. 
9. Co-culture in 3D collagen I gels. 
Operetta ®  / Harmony ®  High Content Screening (HCS) Platform was used to 
analyze the migration and invasion of cancer cells toward macrophages, and vice versa, in 3D 
collagen 1 gels. Monocytes or macrophages were embedded at the bottom of the gels, and KRS 
level-modulated HCT116 cancer cells were embedded at the upper side of the gels. KRS level-
modulated HCT116 cancer cells were embedded at the bottom of the gels, and monocytes or 
macrophages were embedded at the upper side of the gels. HCT116 cancer cells were stained 
with Cell Tracker Green (CMFDA), and macrophages were stained with Cell Tracker Red 
(CMTPX). The location of cells in the gels was taken at Day 5 and Day 10 after embedding. 
The confocal image acquisition performed by the Operetta High Content Screening System 
allows robust and reliable cell counting within different planes of the matrix, leading to graphic 
presentations of the cell numbers in each plane (Y-axis) to depict relative migrations (X-axis) 
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10. Cytokine antibody array. 
Human cytokine antibody array was used to measure the synthesis or secretion levels 
of 42 cytokines by HCT116 cells (parental, KRS-suppressed cells, or KRS-overexpression cells) 
in 3D collagen I gels. Shown in rectangle enclosed boxes are the factors that are highly down-
regulated upon KRS suppression in conditioned medium of HCT116 cells. The Human 
Cytokine Array was used to simultaneously detect differences in cytokine secretion profiles in 
the supernatants of THP-1, human macrophage (monocyte, M1-, M2-polarized) cells. The 
relative expression levels of 102 human soluble proteins were determined.  
11. Analysis of Subcellular Proteome Extraction. 
Cells  were  then subjected  to  membrane  and  cytosol  fractionation  
using  Subcellular  Proteome  Extraction  Kit (Calbiochem, Billerica, MA), as indicated 
by the manufacturer. HCT116 shControl, HCT116 cells stably transfected with shKRS (clones 
of #2 or #5), myc-KRS-overexpressing cells (KRS WT) and other KRS mutants (ΔC5, T52A, 
S207A) were harvested for membrane, nucleus and cytosol fractions. The cell fractions were 
normalized for standard western blot analysis, and probed using antibodies against the 
indicated molecules. The data shown represent three independent experiments. 
12. Immunohistochemistry. 
Dissected colon and lung were fixed and stored in 4% Formaldehyde. The tissues were 
processed, paraffin embedded, and sectioned at 6-μm thickness. After deparaffinization, 
antigen retrieval was performed by boiling the sections for 5 min in sodium citrate solution 
(0.01 M, pH 6). Immunohistochemistry of serial sections of paired normal or tumor colon 
tissues was performed using normal rabbit IgG, normal mouse IgG, KRS (Neomics), CD206 
(Abcam) and CD11c (Invitrogen).  
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13. Real-Time PCR. 
  Total RNA was extracted from cells in 10% FBS-containing condition or in 3D 
collagen I gels, using QIAzol (QIAGEN) according to the manufacturer’s protocol. One 
microgram of total RNA was reverse transcribed using the amfiRivert Platinum cDNA 
Synthesis master mix (GenDepot) and ReverTra Ace qPCR RT Master Mix with gDNA 
Remover (TOYOBO). Primers were designed using Integrated DNA Technologies (IDT) 
software as follows : human CD11b mRNA, forward 5’-CAGTGTGACATCCCGTTCTT-3’ 
and reverse 5’-CACGATCAGGAGGTGGTTATG-3’; human CD11c mRNA, forward 5’-
GTTAGCAGCCACGAACAATTC-3’ and reverse 5’-TCCCTCTGTCCCAGGTTATT-3’; 
human TNF mRNA, forward 5’-GATCCCTGACATCTGGAATCTG-3’ and reverse 5’-
GAAACATCTGGAGAGAGGAAGG-3’; human IL-1 mRNA, forward 5’-
CTCTCACCTCTCCTACTCACTT-3’ and reverse 5’-TCAGAATGTGGGAGCGAATG-3’; 
human IL-6 mRNA, forward 5’-ATAGGACTGGAGATGTCTGAGG-3’ and reverse 5’-
GCTTGTGGAGAAGGAGTTCATAG-3’, CD206, forward 5’-
GGACGTGGCTGTGGATAAAT-3’ and reverse 5’-ACCCAGAAGACGCATGTAAAG-3’; 
IL-10, forward 5’-GCTGGAGGACTTTAAGGGTTAC-3’ and reverse 5’-
GATGTCTGGGTCTTGGTTCTC-3; GAS6, forward 5’- TCTGTGGCACTGGTAGACTAT-3’ 
and reverse 5’- CGCAGACCTTGATCTCCATTAG-3; Fibronectin, forward 5’- 
CCACAGTGGAGTATGTGGTTAG-3’ and reverse 5’- CAGTCCTTTAGGGCGATCAAT-3; 
human KRS (KARS) mRNA, forward 5’- GAGAAGGAGGCCAAACAGAA-3’ and reverse 
5’- CTCAGGACCCACACCATTATC-3’, and human GAPDH mRNA, forward 5’- 







FGF2/GROa/M-CSF cause the dissemination from colon cancer spheroids embedded in 3D 
collagen I gels. 
   Previous results have shown that the physical distance between cancer cells with high 
expression of KRS and surrounding macrophages in cancer tissues is close, suggesting that 
there may be an interaction between cancer cell and macrophages. Therefore, we conducted an 
experiment to check the effect of surrounding macrophages on cancer cells. The effect of 
macrophages around the cancer cells mimics by treating the conditioned medium (CM) of 
macrophages with cancer cells. Previous studies have shown that cancer cells with higher 
expression of KRS are more capable of dissemination and migration in a 3D collagen 
environment. Thus, the dissemination ability of stable cell lines with different KRS expression 
by macrophage effect was observed through time-lapse microscope. CM of macrophages was 
obtained by differentiating human monocytes and human monocyte cell lines THP-1 into M1 
and M2, respectively. HCT116 cells (shControl, shKRS#2, shKRS#5(data not shown)) or 
SW620 cells (shControl, shKRS#2, shKRS#5 (data not shown)) spheroids were embedded in 
collagen 1 gel and treated with CM of macrophages isolated from healthy donor blood. 
Inhibition of KRS expression in HCT116 and SW620 cell lines showed that the suppressed 
dissemination ability was restored by treating CM of M2 macrophages (M2 CM). However, 
when treated with CM of M1 macrophages (M1 CM), KRS-suppression inhibited 
dissemination ability was not recovered. The CM of M1 or M2 macrophages differentiated in 
THP-1 cell line were both disseminated in the KRS-suppression cell lines. (Fig. 2.1A) The 
difference in the CM of macrophages differentiated from healthy donor blood and CM of 
differentiated macrophages from THP-1 cell line is thought to be due to the fact that THP-1 is 
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a cell line isolated from leukemia patient rather than monocytes isolated from the heathy state 
body. The CM of monocytes or THP-1 monocytes isolated from human blood could not affect 
KRS-suppression cell lines. (data not shown) It was observed that phospho-Tyr705 and 
phospho-ERKs were reduced by KRS suppression in HCT116 and SW620 cell lines. We found 
that phospho-Tyr705 and phospho-ERKs were restored when treated with CM of macrophages 
isolated from healthy donors. Especially, it was confirmed that this phenomenon is prominent 
when M2 CM is treated than M1 CM. (Fig. 2.1B) Similarly, phospho-Tyr705 and phospho-
ERKs were also increased when CM of THP-1 macrophages was treated in the same cell lines. 
In addition, we confirmed the expression of Paxillin and phosphor-Tyr118 Paxillin, which is a 
signal required for dissemination. The expression of IB is inhibited by treatment with CM 
of THP-1 macrophages, which suggests that NF-B is activated. And, when the CM of 
macrophages is treated with cancer cells, it can be seen that the effect of M2 CM is larger than 
monocyte, M0, and M1 CM. (Fig. 2.1C and D) We confirmed that KRS-suppression stable cell 
lines, which inhibited the dissemination phenomenon, showed activation of various molecules 
and showed dissemination phenotype when cancer cells were treated with CM of macrophages. 
Therefore, we analyzed CM of macrophages using a cytokine antibody array in order to 
investigate whether any substance present in the CM of macrophages affects the dissemination 
of cancer cells. Because M2 CM affects the dissemination of cancer cells than M1 CM, we 
analyzed cytokines secreted more in M2 CM than monocyte CM or M1 CM. In the CM of 
THP-1 cell line, nine cytokines were more prominent than monocyte or M1 CM. We also found 
that the CM of macrophages isolated from the blood of healthy donor secreted more 18 
substances in M2 CM than monocyte CM or M1 CM. When the results of THP-1 CM and the 
CM of macrophages isolated from blood were combined, it was common that there were six 
cytokines secreted by M2 CM in common. Among them, it was able to be compressed into 
three cytokines (FGF basic, GROalpha, M-CSF) from the results obtained through repeated 
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experiments. (Fig. 2.1E) To confirm whether these three cytokines could affect the 
dissemination of cancer cells, we examined the dissemination of SW620 cell lines in a 3D 
collagen environment. These three cytokines not only increased the dissemination capacity of 
the KRS positive cell line, but also restored the suppressed dissemination ability of the KRS 
suppression cell line. (Fig 2.1F)  In the dissemination ability of cancer cells, immunoblotting 
was performed to confirm whether FGF basic had a specific effect on cancer cells and whether 
other growth factors were not affected. As a result, activation of signal related to dissemination 
could be confirmed only when FGF basic was treated in HCT116 cell lines without being 
influenced by other growth factors, PDGF and VEGF. (Fig. 2.1G) Furthermore, when the CM 
of THP-1 macrophages was treated with HCT116 cell lines, it was confirmed that the 
phosphorylation of FGFR was increased. (Fig. 2.1H) Similarly, when GRO and M-CSF were 
treated with cancer cells, phosphorylation of STAT3 and ERKs were increased. Interestingly, 
we found that GRO and M-CSF treatment in cancer cells in the 3D environment resulted in 
signal activation early in the treatment, unlike FGF basic treatment. (Fig. 2.1I) In the HCT116 
cell lines, mRNAs of these three molecules were examined and it was confirmed that mRNA 
expression was not different between cancer cells that regulated KRS expression. This may be 
due to the dissemination of cancer cells by the effect of paracrine by macrophages. (Fig. 2.1J) 
In order to determine whether these three molecules directly affect the dissemination of cancer 
cells, experiments were conducted to neutralize them by treating the antibodies that can target 
them. The KRS suppression cell lines of HCT116 and SW620 were treated with M2 CM to 
induce dissemination and to mix the antibodies together, respectively. As a result, in the 
HCT116 cell lines, the dissemination phenomenon observed by treating M2 CM with KRS 
suppressed spheroids was not observed in single cells disseminated by treating the antibodies, 
but some protrusive phenotypes were showed. In the SW620 cell lines, when the antibodies 
were treated, there was almost no dissemination of the cancer cells. (Fig. 2.1K) Activation of 
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FGFR by FGFbasic is known to be associated with integrin v3. We investigated whether the 
phenomenon of dissemination by M2CM is due to the interaction between FGFR and integrin 
v3. When the integrin signal was blocked by treatment with M2CM and integrin v3 
antibody, the dissemination ability of cancer cells was decreased. However, it did not 
completely prevent the dissemination of cancer cells. The dissemination of cancer cells by 
M2CM suggests that the FGFR-integrin v3 dependent pathway and the FGFR-integrin avb3 
independent pathway are present. (Fig. 2.1L) Likewise, when the antibody that can target the 
KRS on the membrane was treated, it was confirmed that the cancer cell was partially prevented 
from dissemination. KRS on the membrane is known to provide the crawling force of cancer 
cells through the KRS-Laminin receptor (LR)-integrin 61 interaction in the dissemination 
process of cancer cells. This KRS-LR-integrin 61 pathway also partially contributed to the 
dissemination of cancer cells by M2CM. It is suggested that KRS-independent pathway is also 
present in dissemination by M2CM. (Fig. 2.1M) Taken together, cytokines such as FGF basic, 
GRO, and M-CSF secreted by TAM induce dissemination of surrounding cancer cells. The 
dissemination of cancer cells is an important first step leading to the metastasis of tumor, 
suggesting that modification of the tumor microenvironment by TAM may play an important 
role in cancer cell metastasis. 
GAS6 from KRS-positive tumor cells causes the polarization of macrophages from M1 to 
M2 populations.  
To investigate the effect of cancer cells on peripheral macrophages in the tumor 
microenvironment, CM of HCT116 stable cell lines, which regulated KRS expression, was 
treated with THP1 macrophages (differentiated into M1 and M2, respectively). The mRNA 
expression of IL6, which is known to be secreted mainly from M1 macrophages and The 
mRNA expression of IL10, which is known to be secreted mainly from M2 macrophages, was 
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examined. We also confirmed the mRNA expression of mannose receptor (CD206), a marker 
of M2 macrophages. Interestingly, when CMs of KRS expression-regulated colon cancer cell 
lines were treated, there was no difference in the expression of IL10 and CD206 in M1 
macrophages was found to be increased by treatment of CM of KRS positive cancer cell lines. 
(Fig. 2.2A) Many researches have been conducted on the transition of macrophages with the 
M1 phenotype to macrophages with the M2 phenotype. The mRNA level of several molecules 
known to affect these transitions was examined in the cancer cell lines that regulated KRS 
expression. Among the various molecules, only GAS6 and IL8 showed a marked decrease in 
mRNA expression in KRS suppressed cell lines, and it was confirmed that the expression of 
GAS6 and IL8 was increased as KRS expression was increased. (Fig. 2.2B) In addition, we 
examined 48 cytokines secretion in the CM of KRS expression- regulated cancer cells through 
cytokine antibody array. These results indicate that the higher the expression of KRS in 
colorectal cancer cells, the more cytokines such as angiogenin (ANG) and IL8 are secreted. 
(Fig. 2.2C) To investigate whether GAs6, IL8, and ANG, which have different levels of 
expression and secretion in KRS expression-regulated cancer cells, affect the transition from 
M1 macrophages to M2 macrophages, experiments were conducted to directly treat these 
molecules with macrophages. When Gas6, IL8, and ANG were treated with THP-1 monocyte 
or M1, M2 macrophages, in particular, the mRNA expressions of IL10 and CD206 were 
increased by treating GAS6 in M1 macrophages. (Fig. 2.2D and E) When IL8 and ANG were 
individually treated with macrophages, they did not significantly affect the transition from M1 
to M2. (data not shown) When examined by FACS under the same conditions, it was confirmed 
that the expression of M2 macrophage marker, CD206, was increased by the treatment of Gas6, 
IL8, ANG with M1 macrophages, although there was no significant difference in expression of 
M1 marker, CD11b. (Fig. 2.2F) When CM of stable cell lines regulated KRS expression was 
treated on M1 macrophages, CM of KRS positive cancer cells was found to increase phospho-
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STAT6 in M1 macrophages. (Fig. 2.2G) It is generally known that phospho-STAT1 is increased 
in M1 macrophages and phospho-STAT6 is increased in M2 macrophages. Similarly, it was 
confirmed that phospho-STAT6 was increased by treating Gas6 (and IL8/ANG) with M1 
macrophages.(Fig. 2.2H)  It is known that MerTK acts on the transition from M1 to M2 
through GAS6 in macrophages. Thus, we confirmed whether GAS6 secreted by KRS positive 
cancer cells induces a transition from M1 to M2 macrophages through activation of MerTK. 
As a result, when M1 macrophages were treated with GAS6 (IL8 and ANG), MerTK was 
activated through MerTK phosphorylation.(Fig. 2.2I) Because of this, KRS positive cancer 
cells secrete GAS6, IL8 and ANG, and these cytokines induce the transition from surrounding 
M1 macrophages to M2 macrophages. Cancer cells secrete a number of cytokines, which 
change the surrounding macrophages into TAM, thereby creating a favorable environment for 
cancer cells. 
KRS translocated into nucleus promotes GAS6 mRNA level through transcription factor 
MiTF. 
It was confirmed that GAS6 secreted by KRS positive cancer cells affects peripheral 
macrophages, causing the transition of M1 macrophages to M2 macrophages. To examine the 
mechanism of KRS in cancer cells to regulate the mRNA of Gas6, various KRS mutants were 
used. It has been reported in various researches that KRS is located in various places within 
the cell, and that KRS functions differently depending on its location. There are three ways in 
which KRS can regulate the mRNA of Gas6, depending on where KRS is located in the cell. 
First, KRS in cytosol regulates the expression and activation of transcription factor, which can 
regulate GAS6 mRNA. The second is that KRS directly enters the nucleus and regulates the 
transcription factor to regulate GAS6 mRNA. Finally, the third method is to regulate the 
expression of gas6 by stimulating cancer cells with autocrine effect by KRS secreted from 
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cancer cells. KRS mutants that inhibit intracellular transport of KRS were constructed in 
HCT116 cell lines and gas6 mRNA expression was examined in these mutants such as the KRS 
T52A mutant, which fails to migrate to the membrane, KRS ΔC5 mutant that is not secreted 
out of the cells and the KRS S207A mutant, which does not enter the nucleus. (Fig. 2.3A) 
However, except for the KRS T52A mutant, there was no problem with the dissemination of 
KRS mutants. (Fig. 2.3B) Interestingly, only the KRS S207A mutant was found to show a 
decrease in GAS6 mRNA expression. Other KRS mutants were found to have no effect on 
Gas6 mRNA expression. (Fig. 2.3C) When the CM of KRS mutants were treated to M1 
macrophage, the treatment of KRS S207A mutant CM showed that the M1 macrophages did 
not transition to the M2 macrophages more than the treatment of the other mutants CM. (Fig. 
2.3D) KRS has been reported to enter the nucleus and activate the transcription factor MiTF to 
regulate gene expression in dendritic cells. In the colon cancer cells, the ChIP assay was 
performed to examine the effect of KRS on the transcription factor to regulate GAS6 mRNA 
expression. Based on previous studies, we examined the transcription factors MiTF and c-JUN, 
which are expected to be regulated by KRS. Thus, an experiment to confirm that two 
transcription factors bound to the promoter of GAS6 was designed and shown in a schematic 
diagram. (Fig. 2.3E) As a result, it was confirmed that the transcription factor regulating GAS6 
mRNA by KRS in colon cancer cells was MiTF, not c-JUN. When M2 CM was treated with 
the KRS suppressed cell line, MiTF was attached to the gas6 promoter. (Fig. 2.3F) YH 16899 
inhibits KRS - LR interaction on membrane, which is known to inhibit dissemination by KRS. 
We also examined whether YH 16899 could affect the expression of GAS6, which is regulated 
by KRS present in the nucleus. When several KRS mutants were treated with YH 16899, GAS6 
mRNA expression was not affected at all. (Fig. 2.3G) Since FGF basic, M-CSF, and GRO 
secreted by macrophages induce dissemination of KRS suppressed cells, we examined whether 
these molecules could affect GAS6 expression. (Fig. 2.3H) These three molecules, which 
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induced dissemination of cancer cells, had no effect on GAS6 mRNA expression. Because of 
this, it is anticipated that other substances present in M2CM will affect KRS or MiTF and affect 
GAS6 mRNA expression. 
KRS-positive HCT116 tumor cells prefer to communicate with M2 macrophages rather than 
with M1 macrophages.  
Many results have confirmed that the relationship between these cancer cells and 
macrophages in the tumor microenvironment is affecting each other. Through the co-culture in 
3D collagen 1 gel of cancer cells and macrophages, we attempted to mimic what this 
relationship would be in the tumor microenvironment. 3D co-culture was performed in a 
cornining 48-well plates for 5-10 days, and images were obtained and analyzed through 
Operetta. The cells to be traced were embedded in the bottom part of the collagen gel, and the 
migration distance of the cells was measured every 5 days. When macrophages are tracked, it 
was confirmed that the M2 macrophages migrated more toward the cancer cells than the 
monocytes or M1 macrophages. In addition, the co-culture with KRS positive cancer cells 
showed that the migration of macrophages was further increased. (Fig. 2.4A) Conversely, when 
tracking cancer cells, we confirmed that KRS positive cancer cells migrated more toward 
macrophages than KRS suppressed cancer cells. When co-cultured with M2 macrophages, the 
migration of cancer cells was prominent on 5 days after co-culture. Interestingly, however, 
when we observed 10 days after co-culture, the migration of cancer cells co-cultured with M1 
or M2 macrophages was not significantly different. In other words, when co-cultured for 5 days, 
only M2 macrophages and KRS positive cancer cells were largely attracted. However, when 
co-cultured for 10 days, M1 macrophages and KRS positive cancer cells were also increased 
attraction each other. (Fig. 2.4B) Indeed, in the tumor, cancer cells with different levels of KRS 
expression will be present in the form of solid tumors. In order to mimic such a situation, the 
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KRS positive cell line and the KRS negative cell line were made into one spheroid, and 3D co-
culture was performed. Each cell line was stained with a different fluorescent dye to track KRS 
positive cells (cell tracker green; CMFDA) and KRS negative cells (cell tracker red; CMPTX). 
We confirmed that KRS positive cells only disseminated in spheroids composed of two cell 
lines. However, when M2 CM was treated, both KRS positive cell and KRS negative cell were 
found to be disseminated. This suggests that KRS positive cells are inadequate to induce 
dissemination of KRS negative cells in an environment composed only of cancer cells with 
different levels of KRS expression. (Fig. 2.4C)  It has been reported that there are many 
macrophages in the peripheral region other than the core region of the tumor, and cancer cells 
with high expression of KRS are reported to be present in the marginal portion of these tumors. 
To investigate the relationship between macrophages and highly expressed KRS - expressing 
cancer cells in tumors, we examined the inducible colon carcinoma model in Balb / c female 
mice. KRS expression was higher than normal tissues in tumors generated by chronic 
inflammation, and CD206, which is a marker of M2 macrophages, was present around the 
tumor. (Fig. 2.4D) In addition, inducible colon carcinoma was induced by treatment with 
AOM-DSS in C57BL6 male and female mice KRS + / +, KRS +/- mice. According to the 
differences in expression of KRS, the degree of tumor formation and severity was more 
prominent in KRS + / + mice than in KRS +/- mice. (Fig. 2.4E) Interestingly, KRS +/- mice showed 
higher KRS expression than other normal tissues in the area of colon carcinoma. In addition, 
we observed more macrophages with M2 phenotype than macrophages with M1 phenotype 
around tumor. (Fig. 2.4F) In this regard, in colorectal cancer, KRS expression is increased in 
the tumor region, and M2 macrophages are present around cancer cells having increased 
expression of KRS. Interaction may be expected between the two cells with close physical 
distance, suggesting that such interactions may have a large impact on the tumor 
microenvironment. A stable cell line regulating KRS expression was constructed by CT26, a 
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mouse colon cancer cell line, and confirmed by in vivo system through IV injection. The 
characteristic signaling pathway observed when KRS expression was regulated in cancer cells 
could be obtained in the CT26 cell line as in the case of human colon cancer cell lines. (Fig. 
2.4G) Three weeks after the injection of CT26 cell line, which regulated KRS expression, the 
mice were sacrificed and the tumor formation of the lungs was confirmed. When shControl cell 
lines were injected, the formation of the tumor was markedly greater than that of shKRS # 2 
cell lines. These results suggest that the greater the expression of KRS in cancer cells, the more 
excellent the ability of metastasis. (Fig. 2.4H and I) The KRS expression of cancer cells and 
the infiltration pattern of macrophages around cancer cells were confirmed by IHC in the 
mouse lung tissues. The KRS expression was higher in the tumor-forming region than in the 
normal lung tissue region, and the infiltration of M2 macrophages, not M1 macrophages, was 
noticeable around cancer cells with high expression of KRS. (Fig. 2.4J) KRS expression of 
cancer cells was found to induce attraction and infiltration of the surrounding macrophages, 
especially, macrophages with the M2 phenotype were found around cancer cells with high 
expression of KRS. As the physical distance between cancer cells and macrophages approaches, 
suggesting that the interaction between cancer cells and macrophages is activated, thereby 
creating a tumor microenvironment that facilitates metastasis of colon cancer cells. 
A positive relationship between KRS-positive colon cancer cells and M2 macrophages is 
important in favoring tumor microenvironment for KRS-positive metastatic phenotypes. 
Interaction of cancer cells with high expression of KRS and surrounding macrophages 
may be expected to have an influence on the tumor microenvironment in which they are present. 
It is well known that various cells are present in the tissue, and among them, fibroblasts that 
form ECM greatly contribute to the migration of cancer cells. Thus, normal fibroblasts present 
in the tumor microenvironment were expected to be activated by cancer-associated fibroblasts, 
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which are known to create a favorable environment for tumors through the positive loop 
interaction of cancer cells and macrophages. To confirm this hypothesis, CCD18CO, a normal 
colon cell line, was embedded in 3D collagen 1 gel and the prepared macrophage CM was 
treated for 4 days. THP1 were each differentiated into M1 and M2 macrophages, respectively, 
and then M1 macrophages were treated with CM of HCT116 stable cell lines (shCon, shKRS 
# 2, KRSWT). As a result, CM of M1 macrophages treated with CM of KRS positive cancer 
cells caused a morphological change with a broad fibroblast with a rough surface. And it 
increased LN expression of fibroblast. This result was as if the CM of M2 macrophages was 
treated. (Fig. 2.5A and B). Under these conditions, we examined the mRNA levels of laminin 
and fibronectin, known as ECM, which may affect cancer cell metastasis. The CM of M1 
macrophages treated with KRS positive cancer CM increased the mRNA of ECM components 
of fibroblast as much as the CM of M2 macrophages. (Fig. 2.5C) It is well known that when 
CAF is activated, collagen contraction occurs. When the collagen contraction phenomenon of 
fibroblast was examined under the same conditions, the CM of M1 macrophages treated with 
KRS positive cancer CM showed similar results to the CM of M2 macrophages. In other words, 
CM of KRS positive cancer cells can be expected to transit M1 macrophages to M2 
macrophages. (Fig. 2.5D) Co-culture in 3D collagen environment was performed by making 
HCT116 or CCD18CO and HCT116 as one spheroid. When incubated with HCT116 alone, or 
when HCT116 and CCD18CO were co-cultured together, the results of these 2 cases were not 
significantly different under normal media conditions. However, when M2 CM was treated, 
co-culture of CCD18CO was found to increase the dissemination of cancer cells more than 
HCT116 alone. (Fig. 2.5E)  In colorectal cancer cell lines, the secretion of IL8 and ANG, 
which are cytokines related to angiogenesis, was found to be highly correlated with KRS. Thus, 
to investigate the effect of KRS positive cancer cells on angiogenesis in tumor 
microenvironment, HUVEC and colon cancer cells were co-cultured using a 3D microfluidic 
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device. When co-cultured with KRS positive cells than when co-cultured with KRS negative 
cancer cells, HUVEC were extended to the direction of cancer cells. Through this, it can be 
expected that, within the tumor environment, KRS positive cancer cells will further promote 
angiogenesis. (Fig. 2.5F)  
Cancer cells undergoing epithelial-mesenchymal transition (EMT) and M2-polarized 
macrophage (tumor-associated macrophages (TAMs)) at the invasive front of tumors suggests 
that these two cell types may mutually communicate positively for enhanced metastatic 
activities. KRS-positive colon cancer cells activate macrophages to a TAM-like phenotype by 
Gas6 / IL8 / ANG. Reciprocally, FGF2 / GRO/ M-CSF from TAMs induces cancer cell 
dissemination, forming a positive feedback loop, in co-culture systems. These findings suggest 
that a positive feedback loop between FGF2/ GRO/M-CSF and Gas6/IL8/ANG is importantly 
involved in the cross-talks between macrophages and KRS-positive cancer cells for an efficient 




















Fig. 2.1. FGF2/GROa/M-CSF cause the dissemination from colon cancer spheroids 
embedded in 3D collagen I gels. 
(A) HCT116 and SW620 (shControl, KRS-suppressed stable cells) spheroids were embedded 
in 3D collagen I with concomitant treatment of conditioned media (CM, 30%) from monocytes 
or macrophages derived from human healthy donor blood (M1-, M2-polarized cells) or THP-
1 (M1-, M2-polarized cells). Then, the spheroids were imaged by time-lapse microscopy for 
48 h. (B to D) Spheroids of HCT116 cells (shControl, KRS-suppressed stable cells) embedded 
in 3D collagen I gels in the presence of the macrophages CM (derived human blood or THP-1 
cells) were harvested for whole-cell extracts prior to performing standard western blots for the 
indicated molecules. (E) The Human Cytokine Array was used to simultaneously detect 
cytokine differences between supernatants of THP-1, human macrophage (monocyte, M1-, 
M2-polarized) cells. The relative expression levels of 102 human soluble proteins were 
determined. Blue, red and green rectangles depict for FGF2, GRO and M-CSF, respectively. 
(F) Spheroids of SW620 cells (shControl, KRS-suppressed stable cells) embedded in 3D 
collagen I gels in the presence of the FGF2 (50 ng/ml), GRO (50 ng/ml) and M-CSF (50 
ng/ml) were imaged by time-lapse microscopy for 40 h. (G to I) Spheroids of HCT116 cells 
(shControl, KRS-suppressed stable cells) embedded in 3D collagen I gels in the presence of 
the FGF2 (50 ng/ml), GRO (50 ng/ml) and M-CSF (50 ng/ml) were harvested for whole-cell 
extracts prior to performing standard western blots for the indicated molecules. (J) mRNA 
expression of FGF basic(FGF2), GRO and M-CSF in HCT116 cells (shCon, KRS-suppressed 
stable cells, KRSWT) was measured by pRT-PCR. (K) Spheroids of HCT116, SW620 cells 
(shControl, KRS-suppressed stable cells) embedded in 3D collagen I gels in the presence of 
the M2 conditioned medium or M2 conditioned medium adding functional  anti-human  
cytokine (FGFR1/2 or GRO, M-CSF) blocking  antibody  (10  μg/ml) were imaged by 
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time-lapse microscopy for 48 h. (L) Spheroids of HCT116 shControl stable cell lines  
embedded in 3D collagen I gels in the presence of the M2 CM and/or integrin v3 antibody 
(10  μg/ml)  were imaged by time-lapse microscopy for 24 h. (M) Treatment of anti-KRS 
antibody targeting KRS on membrane of HCT 116 colon cancer cells with wild type KRS 









Fig. 2.2. GAS6 from KRS-positive tumor cells causes the polarization of macrophages 
from M1 to M2 populations.  
(A) Cytokine mRNA levels of macrophages (M1 or M2) treated with the CM (30%) prepared 
from indicated-tumor HCT116 spheroids, by qRT-PCR. (B) mRNA levels of several genes 
related to M1-M2 macrophages transitions were measured in HCT116 cells by pRT-PCR. (C) 
Human cytokine antibody array was used to measure the synthesis or secretion levels of 42 
cytokines by HCT116 spheroids (of parental, KRS-suppressed cells, or KRS-overexpression 
cells) embedded in 3D collagen I gels. Shown in rectangle enclosed boxes are the factors that 
were highly down-regulated upon KRS suppression in the conditioned media of the HCT116 
spheroids. (D) mRNA levels of cytokines related macrophage polarization in spheroids of 
HCT116 (stable shControl, KRS-suppressed stable cells, and stably myc-KRS WT 
overexpressing cells) colon  cancer  cells  embedded  in  3D  collagen  I  gels were 
analyzed by qRT-PCR. (E) Cytokine mRNA levels of monocytes or macrophages (M1 or M2) 
treated with GAS6 (10 ng/ml), IL8 (50 ng/ml), and/or angiogenin (50 ng/ml) into their culture 
media for 4 days. (F) When M1 macrophages were treated with HCT116 cancer cells (shCon, 
shKRS # 2, KRSWT) CM or Gas6 and / or IL8 and / or ANG, markers of macrophages were 
identified by FACS. (G to I) Monocytes or macrophages (M1 or M2) treated with HCT116 
(stable shControl, KRS-suppressed stable cells, and stably myc-KRS WT overexpressing cells) 
conditioned media or GAS6 (10 ng/ml), IL8 (50 ng/ml), angiogenin (50 ng/ml) into their 
culture media for 4 days were were harvested for whole-cell extracts prior to performing 










Fig. 2.3. KRS translocated into nucleus promotes GAS6 mRNA level through 
transcription factor MiTF. 
(A) The localization of KRS in HCT 116 colon cancer cells with wild type KRS expression or 
KRS suppression, mutant KRS expression was confirmed by proteome extraction kit.  (B) 
Spheroid of HCT 116 colon cancer cells with wild type KRS expression and mutant KRS 
expression embedded on 3D collagen 1 gel. Then, the spheroids were imaged by time-lapse 
microscopy. (C) The transcription level of GAS6 in HCT 116 colon cancer cells with wild type 
KRS expression or KRS suppression, mutant KRS expression was measured by qRT-PCR. (D) 
When M1 macrophages were treated with HCT116 cancer cells (wild type KRS expression and 
mutant KRS expression), markers of macrophages were measured by qRT-PCR. (E) Schematic 
representation of the promoter regions of the human GAS6 gene with putative MiTF or c-JUN 
binding sites and the PCR amplification region of the chromatin immunoprecipitates. (F) 
Chromatin immunoprecipitated from cells using normal IgG or anti-MiTF (Region 1) or anti-
c-JUN (Region 2) antibodies without or with M2 CM treatment were processed for PCR using 
primers for the GAS6 promoter regions or control regions without binding sites. (G) When 
treated with YH 16899 on HCT116 KRS mutant cell lines, GAS6 mRNA levels were confirmed 
by qRT-PCR. (H) The transcription level of GAS6 was examined when FGF2, GRO, and M-













Fig. 2.4. KRS-positive HCT116 tumor cells prefer to communicate with M2 macrophages 
rather than with M1 macrophages. 
(A) Monocytes or macrophages were embedded at the bottom of the gels, and KRS level-
modulated HCT116 cancer cells were embedded at the upper side of the gels. Migration of 
cells analysed using Operetta ®/ Harmony® High Content Screening (HCS) Platform. (B) KRS 
level-modulated HCT116 cancer cells were embedded at the bottom of the gels, and monocytes 
or macrophages were embedded at the upper side of the gels. HCT116 cancer cells were stained 
with Cell Tracker Green (CMFDA), and macrophages were stained with Cell Tracker Red 
(CMTPX). The location of cells in the gels were taken at Day 5 and Day 10 after embedding. 
(C) HCT116 shControl stable cells were stained with CMFDA, and shKRS#2 stable cell lines 
were stained with CMTPX. These two cell lines were performed co-culture in 3D collagen 
environment. (D to F) Expression pattern of macrophages and M1/M2 macrophage 
subpopulations in colonic tissue during ulcerative colitis-colorectal carcinoma (UC-CRC) 
carcinogenesis. The expression pattern of macrophages was assessed by 
immunohistochemistry using an anti-CD11c antibody, anti-CD206 antibody and anti-KRS 
antibody. Hematoxylin was used to stain the nuclei. (G) KRS suppressed stable cell line was 
constructed in CT26 colon cancer cells and confirmed by qRT-PCR and immunoblotting. (H 
to J) The tumor formed by CT26 stable cell lines (shCon, shKRS#2) through tail vein injection 













Fig. 2.5. A positive relationship between KRS-positive colon cancer cells and M2 
macrophages is important in favoring tumor microenvironment for KRS-positive 
metastatic phenotypes. 
(A) Human colon normal fibroblast CCD18CO in 3D collagen environment were treated with 
CM of THP1 monocytes or macrophages (M1 or M2) into their culture media. After 4 days, 
CCD18CO cells were immune-stained with -sma. (B to D) After differentiation of THP-1 
into M1 and M2, M1 macrophages were treated with HCT116 cancer cells CM. The CM of 
macrophages was treated with CCD18CO. Extracellular matrix (laminin alpha1, fibronectin) 
mRNA levels of human colon fibroblast CCD18CO treated with THP1 monocytes or 
macrophages (M1 or M2) into their culture media for 4 days measured by qRT-PCR. 
Representative images of fluorescent Laminin/DAPI staining in fibroblasts. And collagen 
contraction by fibroblasts was measured. (E) CM of M2 macrophages was treated with 
CCD18CO for 2 days. 3D co-culture of HCT116 cells stained with CMFDA (green) and 
CCD18CO stained with CMTPX (red) was performed. (F) HCT116 cells (shCon, shKRS#2, 
KRSWT) and HUVEC were co-cultured in a 3D microfluidic system. (G) A scheme that 
models the phenomenon that affects tumor microenvironment through positive-loop interaction 











The most important cause of cancer mortality is metastasis. Metastasis is the growth 
of cancer cells through the interaction of cancer cells in new places, starting with the delivery 
of cancer cells to specific organs by blood flow and other factors [30]. Cancer epithelial cells 
are regulated in the activity and expression of proteins FAK, Src, paxillin, and ERK, which are 
involved in adhesion, invasion and migration of cells, and cell-cell adhesion, extracellular 
matrix (ECM) attachment. Recently, it has been confirmed that metastatic heterogeneity in 
circulating tumor cells (CTC), incomplete EMT phenotype cells, which maintain some 
epithelial type tendency may have the advantage of colonization again at the distal metastatic 
site.in order to transfer [42].  
The various functions of metastatic cancer cells, including cell migration and invasion, 
are greatly influenced by the microenvironment around the cells during cell metastasis [32]. 
Various cells and factors present in the microenvironment of the tumor promote tumor 
angiogenesis and assist in the invasion and metastasis of tumor cells [33]. Tumor Inflammatory 
cytokines expressed in cancer cells as well as various immune cells in the microenvironment 
provide a good environment for tumor cells to grow and migrate and infiltrate while forming 
an inflammatory network [43]. IL-1β, IL-6, IL-8 and TNF-α, which are the most frequently 
expressed cytokines in many cancers, are regulated by NF-κB and STAT3 and induce cancer 
promotion. These cytokines are produced in the tumor microenvironment and induce the 
expression of MMP-like metastatic and angiogenic genes and growth factors such as VEGF, 
IL-8, IL-6, TNF-α and TGF-β [44-46]. Cytokines secreted from immune cells and tumor cells 
affect the signaling pathway through autocrine/paracrine method, allowing various 
physiological functions in the cell [47]. Thus, the immune cells and tumor cells have an organic 
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relationship with each other and carry out studies to identify and analyze the organic 
networking of the cancer cells and the surrounding cell environment, and to identify the 
functions of the cell [32, 48]. In order to mimic the in vivo environment, a 3D cell culture study 
supplemented with the disadvantages of 2D with an artificial cell form was developed [49]. 
Therefore, in vitro 3D cell culture can be a good alternative to actual cell morphology and 
function studies, and furthermore, interactions with microenvironment [50]. By understanding 
the mechanisms by which the cell-mediated cell functions of the cancer cells, such as migration 
/ invasion, are regulated through interaction between the cells and the microenvironment 
around the three-dimensional cell [51, 52]. 
This study was carried out to investigate the expression of KRS in the colon cancer 
cell line. KRS plays an important role in linking lysine to the corresponding tRNA using ATP 
[53]. Recently, it has been reported that KRS also plays an important role in various cellular 
physiological phenomena such as inflammation, virus assembly, autoimmune disease, and 
promotes cancer cell migration, in addition to protein synthesis [6, 7, 54]. Especially, in the 3D 
culture system, the KRS / LR / integrin interaction is important for dissemination in the tumor 
spheroid. ERK and PXN phosphorylation is important as a downstream signal, and they affect 
the focal adhesions, leading to a crawling force for dissemination [40]. The aim of this study is 
to analyze the interaction of KRS with cellular microenvironmental factors in the cellular 
environment composed of 3D collagen gel. To co-cultivate colon cancer cells, tumor-associated 
macrophages, and HUVECs (Human Umbilical Vein Endothelial Cells) to consider various 
cells and factors present in the microenvironment of the tumor. To confirm the role of these 
cell interactions in terms of metastasis of colon cancer cells, neovascularization of tumor 
vessels, and function of immune cells.  
In this study, we found that cancer cells with high expression of KRS secrete GAS6 
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and activate macrophages into TAM-like phenotypes. It is well known that M2 macrophages 
play a major role in the tumor microenvironment [38]. Cancer cells are attracted to surrounding 
monocytes and differentiate into M1 or M2 macrophages [34]. Usually, M1 macrophages 
secretes cytokines such as TNFα, IL6, IL1α, and has anti-tumoric functions. The other hand, 
M2 macrophages are known to have protumoric function by secreting cytokines such as IL10 
and TGFβ [55]. Thus, it is important to note that macrophages recruited by several cytokines 
secreted by colon cancer cells undergo transition from M1 to M2 by KRS-positive cancer cells. 
KRS-mediated GAS6 affects these M1-M2 transitions, indicating that KRS has a great ability 
to create a prometastatic environment. 
Activated macrophages then produce FGF2, GROα, and M-CSF to induce 
dissemination of cancer cells to form a positive feedback loop. The dissemination ability of 
cancer cells is very important as a stepping stone to metastasis [56]. It is well known that several 
cancer cells having a heterogeniety property, which affects cancer cells [1]. KRS- high 
expressed cancer cells with high disseminating ability induce the surrounding macrophages to 
have a TAM-like phenotype, and activated macrophages eventually give dissemination ability 
to KRS-negative cancer cells. When FGF2, GROα, and M-CSF were treated, the activation 
rates of the molecules related to dissemination were different. This phenomenon suggests that 
GROα and M-CSF, which induce activation in a short time, are involved in the initial 
dissemination of cancer cells, and FGF2, which can maintain its activation for a long time, 
gives power to become the driving force even at the end of dissemination. These positive loops 
are essential for promoting the metastasis of colorectal cancer cells and the prognosis of 
patients with colorectal cancer is poor. Our results indicate that KRS-positive cancer cells 
located in the stromal region of the tumor have excellent ability to activate macrophages to 
form a tumor microenvironment for tumor formation and metastasis.  
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We report that changes in secreted cytokine profiles are important for cancer cell 
dissemination and macrophage activation. FGF2 / M-CSF / GROα secreted M2 macrophages 
induced dissemination of colon cancer cells through activation of STAT3, ERK. Among the 
cytokines induced during dissemination, GAS6 is also responsible for the transition from the 
M1 macrophage to the M2 macrophage [57]. Other increased cytokines have also been found 
to be important in other aspects of the tumor microenvironment, such as IL-8 and angiogenin 
in angiogenesis [58-62]. In vivo, it has been reported that colon cancer cells and macrophages 
move with each other and interact with each other to induce invasion of one another. It is shown 
that GAS6 of colon cancer cells with high expression of KRS and FGF2 / GROα / M-CSF of 
TAM form a positive feedback loop to maintain or promote the dissemination and metastasis 
of cancer cells. These results provide an explanation for the colocalization of TAM and cancer 
cells in the invasive front of the tumor with clinical sample analysis. As a results, these 
interaction affected fibroblast nearby cancer cell and macrophages and gained phenotype of 
cancer-associated fibroblasts. And these CAFs induced dissemination of colon cancer cells by 
producing extracellular matrix, such as laminin and fibronectin.  
We have found that KRS is significantly induced in cancer cells with excellent 
dissemination ability, and that these cancer cells are involved in macrophage activation by 
increasing secretion of GAS6, further promoting dissemination of cancer cells to form a self-
reinforcing loop. We also found that GAS6 acts much more on M2 macrophage polarization 
than IL8 or angiogenin. In addition, when KRS is blocked from transferring to the nucleus, 
there is no significant effect on macrophage activation by conditioned medium of KRS S207A 
mutant cancer cells. KRS suggests that it may be possible to play an essential role in initiating 
a positive feedback loop. In summary, positive loop interaction between cancer cells and 
macrophages through KRS promotes dissemination of cancer cells and has a significant effect 
on tumor-microenvironment formation. This study suggests a new approach to anti-cancer 
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research that considers the microenvironment of the tumor. Especially in inflammatory 
cytokines that affect the metastasis and neovascularization of colon cancer among cytokines 
that are abundant in the tumor microenvironment. In addition, this study can be used as a useful 
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3차원적 콜라젠 환경에서 대장암세포의 침윤적 이탈을 위한  
Lysyl-tRNA 합성효소의 기능 
 
남 서 희 
 
종양의 미세 환경은 암의 발생과 전이에 중요한 역할을 한다는 것이 잘 
알려져 있다. 암세포의 세포-세포 및 세포-기질 부착 특성은 암 전이를 차단하
기 위해 표적화 될 수 있다. 세포질의 lysyl-tRNA 합성 효소 (KRS 또는 
KARS)는 본래 단백질 합성 과정에서 기능을 하지만, 세포막에 존재할 수 있는 
KRS는 암전이에 관여한다고 확인한 바 있다.  
본 연구는 3D 콜라겐 I 겔에서 KRS 양성 세포가 세포 이탈성 표현형을 
명확하게 보인 반면, KRS 억제 세포는 이탈성 표현형이 차단된다는 것을 발견했
다. 또한, KRS-의존적 침윤성 이탈 활성은 ERK/paxillin 활성을 유도하는 세포
막 상의 인테그린 α6 및 p67 라미닌 수용체와의 연관성 있음을 확인하였다. 그
리고 KRS 억제에 의한 세포 이탈성 표현형의 감소는 ERK/또는 paxillin의 
transfection에 의해 회복하였다. 따라서, 3차원 세포배양 환경에서 대장암세포 
내의 KRS는 p67 라미닌 수용체 (p67LR)/인테그린61/ERKs/Paxillin 신호 연
결을 통해 암세포의 이탈 및 이동을 촉진시켰으며, 이는 세포가 이탈하는 동안 
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견인력이 생성됨을 추정할 수 있다.  
침윤성 종양의 암세포 및 종양 관련 대식세포 (TAM; Tumor-
associated macrophage)의 근접 가능성은 이 두 세포 유형이 상호 작용할 수 
있음을 시사한다. 따라서 KRS-의존적 암덩어리에서 암세포의 이탈에 대식세포
가 미치는 영향을 분석하였다. KRS 발현이 높은 대장암 세포에서 사이토카인을 
분석한 결과, KRS 발현이 낮은 세포보다 KRS 발현이 높은 세포가 GAS6, IL8, 
angiogenin을 더 많이 발현하였다. 그 중에서 GAS6는 M1에서 M2 집단으로의 
대식세포의 polarization 야기하는데 주로 역할을 하였다. 핵으로 이동한 KRS는 
GAS6의 promoter에 결합이 가능한 MiTF를 통해 GAS6 mRNA의 발현을 증가
시켰다.  
이러한 KRS 매개 암세포의 이탈은 크게 2가지의 KRS 역할에 의해 의존
적임을 밝혔다. 첫째, 핵으로 이동한 KRS는 GAS6의 전사를 조절하여 주변의 대
식세포들을 M2 집단으로 분극화시킨다. M2 대식세포에서 분비되는 FGF2/GRO
α/M-CSF는 암세포에서 ERKs/paxillin 및 STAT3와 NFkB를 포함하는 세포 
내 신호 전달 경로를 활성화시켜 KRS 발현이 높은 세포뿐만 아니라 발현이 낮
은 세포에서도 암세포 이탈 표현형을 유발한다. 둘째, 세포막으로 이동한 KRS는 
라미닌 수용체와 함께 세포–ECM 상호작용에 매개하여, 세포 이동에 필요한 견
인력 생성을 위한 세포 내 신호 전달 연계를 일으키는 역할한다.  
정상 섬유아세포는 M2 대식세포 CM의 처리에 의해 암 관련 섬유 모세포
(CAF; Cancer-associated fibroblast)로 분화되는 것으로 나타났고, CAF의 라
미닌 발현을 유도하여 KRS 양성 암세포의 이탈 및 이동을 유도할 수 있는 미세
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환경을 구성한다. 결론적으로 대장암 세포 내에서의 높은 KRS 발현은 전이성 세
포가 주변 조직으로의 침투 혹은 이탈을 용이하게 한다는 것을 알 수 있었기에, 
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